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Abstract 
 
 Bacillus anthracis exists in two morphologically distinct states, the spore and the 
vegetative cell.  The deadly animal and human disease anthrax results from B. anthracis 
spores entering a suitable host and transitioning to a toxin producing vegetative cell 
through germination.  The spore cortex is a modified peptidoglycan structure that is 
critical for spore stability and dormancy and must be hydrolyzed during germination to 
allow vegetative-cell outgrowth.  In Bacillus anthracis, this process was thought to 
involve the enzymatic action of a group of proteins called germination-specific lytic 
enzymes (GSLEs).  I have shown that the GSLEs SleB, CwlJ1 and CwlJ2 are all involved 
in cortex hydrolysis and that a second pathway, host-lysozyme induced germination, is 
capable of degrading the cortex in vivo.   
Traditional nutrient based germination requires either SleB or CwlJ1, both in vitro 
and in vivo.   In the absence of these two primary GSLEs, CwlJ2 provides minimal cortex 
hydrolyzing activity and germination rates are severely decreased.  Mutant spores lacking 
all three GSLEs (ΔsleB/cwlJ1/cwlJ2) are unable to complete germination in nutrient rich 
medium in vitro.  Although ΔsleB/cwlJ1/cwlJ2 spores are incapable of germinating in 
response to nutrients, these mutants are able to germinate at a low rate when incubated in 
serum, whole blood, or a solution containing purified lysozyme.    
   
ix 
 
Spores lacking SleB and CwlJ1 as well as ΔsleB/cwlJ1/cwlJ2 spores are highly 
attenuated in a mouse model of inhalation anthrax.  Host lysozyme in the lungs causes 
germination of ΔsleB/cwlJ1/cwlJ2 spores in vivo.  Due to this host factor dependent 
germination, ΔsleB/cwlJ1/cwlJ2 spores remain virulent at high infectious doses.  When 
lysozyme M-/- knockout mice were challenged with ΔsleB/cwlJ1/cwlJ2 spores, the mutant 
was significantly more attenuated compared to a wild-type mouse infection.  Also, serum 
and bone marrow-derived macrophages from lysozyme deficient mice were unable to 
induce germination of ΔsleB/cwlJ1/cwlJ2 spores.   
Cortex hydrolysis is a critical barrier in the process of spore germination.  This 
work provides a more complete understanding of this process for B. anthracis spores both 
in vitro and in vivo. 
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Chapter I 
Introduction 
 
The bacterial spore, and its concomitant sporulation and germination capabilities, 
are critical to the life cycles of the Bacillus and Clostridium genera.  For all firmicute 
species capable of forming spores, the developmental processes of spore formation and 
germination appear conserved at both genetic and mechanistic levels.  The resistance 
properties and extreme longevities of dormant bacterial spores allow bacteria to survive, 
in a dormant form, long periods of nutrient deprivation and challenging physical and 
chemical stresses (Nicholson, Munakata et al. 2000).  Within the large group of spore-
forming species there are several that are severe human and animal pathogens and, as 
such, are the focus of biomedical research efforts.  
Bacillus anthracis, the causative agent of anthrax, has been the subject of renewed 
research interest in the last decade.   Ten years ago, following the September and October 
2001 terrorist acts in the United States, B. anthracis was identified as a Select Agent by 
the Centers for Disease Control and Prevention (http://www.selectagents.gov) and the 
United Stated Department of Agriculture (http://www.aphis.usda.gov/) because of the 
potential use of this bacterium as an agent of bioterrorism.    Like other spore-forming 
species, B. anthracis spores are very stable in the environment, remaining viable for 
hundreds of years (Gest and Mandelstam 1987; Cano and Borucki 1995).  This longevity 
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causes decontamination efforts to be extremely difficult and costly (Turnbull 1996; WHO 
2008).  In addition to their extreme persistence in nature, B. anthracis spores are highly 
infectious and are the etiologic agents for all forms of anthrax, with each variation 
dictated by their point of entry into the host (Druett, Henderson et al. 1953; Navacharoen, 
Sirisanthana et al. 1985; Sirisanthana, Nelson et al. 1988; Dixon, Meselson et al. 1999; 
Friedlander 1999; Sirisanthana and Brown 2002).     
In the early 20th century, B. anthracis was used as a weapon of war, perhaps its 
first well-documented use as a bioweapon.  During World War I, Germany intentionally 
infected the horses of neutral countries that were aiding the allied powers (Wheelis 1999).  
In the years following World War II, B. anthracis research interest increased with several 
countries including the United States, the United Kingdom and the USSR conducting 
research into the defensive measures against, and offensive capabilities of, this bacterium 
(Hammond and Carter 2002).  The 1979 accidental release of B. anthracis spores from a 
Soviet weapons plant in Sverdlovsk and the Amerithrax attacks through the US mail in 
2001 each prompted intense periods of research interest into this pathogen (Meselson, 
Guillemin et al. 1994; Jernigan, Stephens et al. 2001; Jernigan, Raghunathan et al. 2002).   
This introduction will outline unique traits of B. anthracis, with additional focus 
on the spore, which contribute to pathogenicity.  I will also discuss closely related 
pathogens, anthrax pathology, recognition of spores by host immune cells, role of 
redundant germinant receptors in host infection, and the array of germination-specific 
lytic enzymes used to breakdown spore cortex during the breaking of dormancy. 
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Taxonomy 
 The ability to form endospores, and the subsequent transition to vegetative cells 
through germination, are traits of a large group of bacteria known as spore-forming 
bacteria. Among spore-forming bacteria, the genera Bacillus and Clostridium are the 
most actively studied.  The mechanistic steps of spore germination and many of the 
proteins that are involved, such as germinant receptor proteins and germination-specific 
lytic enzymes, are shared between species of these two genera.   
There are at least 25 genera that include species identified as aerobic endospore-
forming bacteria (AEFB) (Fritze 2004).  Among AEFB, the genera Bacillus and 
Paenibacillus contain the vast majority of spore-forming species.  The Bacillus genus 
contains two well-defined taxa, the non-pathogenic B. subtilis group, and the B. cereus 
group to which B. anthracis is assigned (Fritze 2004).  B. subtilis, and other closely 
related species within this group, have received a very high level of research attention 
due to their relative ease of genetic manipulation and lack of pathogenicity.  In its role as 
a well-studied model organism for spore forming bacteria, B. subtilis has provided the 
foundation for much of our understanding of spore structure and spore germination 
(Driks 1999; Popham 2002; Setlow 2003).  The B. cereus group contains pathogenic 
species such as B. anthracis, B. cereus, and B. thuringiensis, as well as non-pathogenic 
species including, B. mycoides, B. psudomycoides, B. weihenstephanensis, and B. 
medusa.  Among the pathogenic species of this group, there is extremely low sequence 
diversity across chromosomal DNA (Ivanova, Sorokin et al. 2003; Read, Peterson et al. 
2003).  In fact, some studies have suggested that these three bacteria should be 
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reclassified as a single species (Helgason, Caugant et al. 2000; Helgason, Okstad et al. 
2000).  Despite their similarities, B. anthracis, B. cereus and B. thuringiensis have very 
different virulence characteristics and a diverse host tropism (Jensen, Hansen et al. 2003; 
Rasko, Altherr et al. 2005).  The genetic basis for this diversity has mostly been attributed 
to variances within a group of plasmids carried by these bacteria that are typically species 
specific (Rasko, Rosovitz et al. 2007).  B. anthracis carries two such plasmids, pXO1 and 
pXO2, which contain genes encoding a tripartite toxin and biosynthetic genes required 
for production of a poly-D-glutamic acid capsule respectively (Okinaka, Cloud et al. 
1999; Pannucci, Okinaka et al. 2002).   These two components are essential virulence 
factors for B. anthracis and are also the most reliable means of species identification 
(Mock and Fouet 2001).  Similarly, B. thuringiensis specific plasmids encode genes for 
crystal proteins, a group of δ-endotoxins that have been extensively studied by the 
agricultural industry for use as biopesticides (Hofte and Whiteley 1989).  B. cereus 
strains contain a wide array of different plasmids, many of which encode specific toxins 
that dictate disease, but none of which are universally conserved across this species 
(Rasko, Rosovitz et al. 2007).  The plasmid-based nature of virulence factors within this 
group of closely related species is cause for concern over the potential of horizontal gene 
transfer leading to new host specificity (Hoffmaster, Ravel et al. 2004). 
 5 
 
Anthrax 
 As initially described by Robert Koch, B. anthracis is the etiological agent of the 
disease anthrax (Koch 1877).  It exists in two morphologically distinct forms, the spore 
and the vegetative bacillus.  Koch went on to show that the spore form of the bacterium 
initiates disease once it has entered a suitable host (Koch 1881).  Although grazing 
ruminants, such as cattle and sheep, are the most common hosts of B. anthracis infection 
it is believed that most mammals are susceptible to the bacterium (Dixon, Meselson et al. 
1999).  The most common form of the disease in natural veterinary outbreaks is 
oropharyngeal anthrax.  This occurs when spores in the soil enter the body of grazing 
herbivores (domesticated or wild) through abrasions in the mouth or pharynx 
(Navacharoen, Sirisanthana et al. 1985; Quinn and Turnbull 1998; Glomski, Corre et al. 
2007).   A second form of the disease, gastrointestinal anthrax, occurs when spores are 
ingested, usually from the consumption of contaminated meat (Sirisanthana, 
Navachareon et al. 1984; Dixon, Meselson et al. 1999; Sirisanthana and Brown 2002; 
Watts, Hahn et al. 2008; Watts, Hahn et al. 2009).  The most common form of the disease 
in human cases is cutaneous anthrax.  This occurs when spores cross the epidermis 
through small cuts or abrasions, and results in a self-contained black eschar at the site of 
infection (Dixon, Meselson et al. 1999; Friedlander 1999).  This is the least severe form 
of anthrax and is often resolved without medical intervention (Smego, Gebrian et al. 
1998).  However, in some cases of cutaneous anthrax, bacilli can enter the blood stream 
causing toxemia and death (Dixon, Meselson et al. 1999).  The final and most severe 
form of the disease is inhalational anthrax.  This occurs when spores are taken up into the 
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lungs and is often fatal (Druett, Henderson et al. 1953; Dixon, Meselson et al. 1999).  
Because this form of anthrax is the most severe and is therefore the most likely targeted 
pathway for bioterrorism applications of B. anthracis, it has received the most attention 
from researchers in the community and will be the focus of the remainder of this chapter.   
 
Spore-phagocyte interactions in vivo  
It has been a long held belief in the field that spores entering the lungs associate 
with phagocytes and are trafficked to nearby lymph nodes where the bacteria escape 
causing a widespread infection.   This model was first suggested in a study published by 
Ross in 1957 that used guinea pigs as a model organism to study inhalation anthrax 
(Figure 1.1) (Ross 1957).  Since then, several groups have attempted to confirm this 
hypothesis and to determine the exact point in the internalization process where spore 
germination occurs.   In her initial study, Ross relied on two new methods for accurately 
determining the fate of B. anthracis spores entering the lung.  The first was a differential 
staining technique that distinguished dormant spores from those that had begun 
germination.  Vegetative cells were identified by both their morphology as well as their 
staining properties.  Second, a new method for rapid fixation of pulmonary tissue in 
formaldehyde was developed.  Following infection, animals were anesthetized then 
euthanized by removing the blood and perfusing the tissue with 4% formaldehyde.  This 
effectively halted spore germination immediately providing a snapshot of the infection.  
Using these techniques, Ross found that B. anthracis spores in the lungs are rapidly taken 
up (less than 35 minutes) by alveolar phagocytes that she believed were macrophages.  
Although no vegetative growth or spore germination was observed in the extracellular  
 7 
 
 
 
 
 
Figure 1.1: Model of inhalation anthrax progression based on the 1957 study by 
Ross.   
 (1) Aerosolized spores are inhaled.  (2) Alveolar macrophages phagocytose spores in the 
lungs.  (3) Macrophages containing spores are trafficked through the lymphatic system to 
a mediastinal lymph node.  (4) Spores germinate within the macrophage while en route 
and vegetative cells begin to divide.  (5) Once inside the lymph node, vegetative bacilli 
are released and bacterial growth continues.  (6) Vegetative cells escape the lymph node 
into the circulatory system causing bacteremia, toxemia and eventually death.  Artwork 
by Nicole Biltz. 
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lung tissue (there is typically no acute pneumonia during inhalation anthrax until very 
late in the disease, if ever), macrophages were seen to contain dormant spores, 
germinating spores and bacilli at various time points between 0 and 18 hours post 
infection.  After 18 hours, vegetative cells were predominantly present and by 24 hours 
vegetative cell division was seen in the lymph nodes, free of the macrophages.  B. subtilis 
spores did not show signs of germination following infection and no vegetative cells were 
found.  Ross concluded from this study that anthrax was not a traditional pneumonia, but 
that spores were engulfed by lung phagocytes, and only once bacteria were trafficked to 
lymph nodes, and released, did they cause a general bacteremia.   The model established 
by Ross in 1957 has been further studied and refined by many groups using the newest 
technologies available. 
 More recently, fluorescently activated cell sorting and confocal microscopy have 
been used to further define the interaction between B. anthracis spores and lung 
phagocytes following infection (Cleret, Quesnel-Hellmann et al. 2007).  In agreement 
with Ross, Cleret et al. found that spores were engulfed by alveolar macrophages within 
10 minutes of infection.  However, these cells were not the phagocytes responsible for 
transport to the lymph nodes.  Within 30 minutes of infection, dendritic cells in the 
interstitial space of the lungs were able to sample spores without crossing the lung 
epithelial barrier.  These cells then trafficked the spores to the draining lymph nodes.  
The role of dendritic cells in spore trafficking was confirmed using transgenic mice in 
which these cells could be transiently depleted (Shetron-Rama, Herring-Palmer et al. 
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2010). This resolution of lung phagocytic cell type was not available to Ross in the 
1950s.   
Work done by Guidi-Rontani and colleagues also found that B. anthracis spores 
rapidly associate with mononuclear phagocytes in the lungs (Guidi-Rontani, Weber-Levy 
et al. 1999).  Guidi-Rontani et al. developed polyclonal antibodies against spores and 
vegetative bacilli to distinguished dormant and germinated spores using 
immunofluorescence confocal microscopy.  Using these tools, they found that germinated 
spores were associated with phagolysosomes within phagocytes collected from 
bronchoalveolar lavage (BAL).  They also showed that spores only germinated when 
associated with phagocytes, not in the presence of BAL fluid alone.  This further supports 
the idea that spores do not germinate in the extracellular space of the lungs, but only 
inside alveolar phagocytes.  
 Despite the abundance of evidence supporting the theory of macrophage/dendritic 
cell-associated germination and trafficking to lymph nodes, there remain many studies 
that find conflicting results.  Glomski and colleagues have seen that germination can 
occur at the initial site of inoculation (Glomski, Corre et al. 2007; Glomski, Dumetz et al. 
2008).  This was done using a capsulated non-toxigenic strain in which a 
bioluminescence cassette was expressed under the pag promoter.  Therefore, only cells 
that had resumed metabolic activity, or had active expression from the pag promoter 
would be detected.   This difference cannot be solely attributed to the new technique 
employed.  Sanz et al. used a similar model in which the bioluminescence cassette was 
expressed under the sspB promoter or the pag promoter to produce light in germinating 
spores or vegetative cells respectively (Sanz, Teel et al. 2008).  In this study, spores were 
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seen to germinate in the lung tissue, but only when associated with macrophages.  
Additionally, Sanz et al. found no germination within the nearby lymph nodes. This study 
suggests that spore germination occurs primarily within the phagocyte while in transit to 
the lymph node.  Still other groups have found that spores remain dormant in the lungs 
for several days or even weeks (Henderson, Peacock et al. 1956; Friedlander, Bhatnagar 
et al. 1993; Pickering, Osorio et al. 2004; Cote, Van Rooijen et al. 2006; Heine, Bassett et 
al. 2007; Loving, Kennett et al. 2007). 
In addition to in vivo studies tracking the movements of B. anthracis spores 
within a host, several groups have used in vitro cell co-culture techniques with primary 
phagocytes as well as transformed cell lines to study the interaction between spores and 
immune cells (Dixon, Fadl et al. 2000; Ireland and Hanna 2002; Weiner and Hanna 2003; 
Kang, Fenton et al. 2005; Ribot, Panchal et al. 2006; Basu, Kang et al. 2007; Hu, 
Emerson et al. 2007; Gut, Tamilselvam et al. 2011).  RAW 264.7 cells, a murine 
macrophage-like cell line, are capable of rapidly phagocytosing spores of several bacillus 
species including B. subtilis, B. megaterium, and B. anthracis.  Association of B. 
anthracis spores with phagocytic cells leads to germination, while the spores of the 
closely related but non-pathogenic species are not triggered to germinate (Dixon, Fadl et 
al. 2000; Ireland and Hanna 2002; Weiner and Hanna 2003).  In the germination model 
originally described by Ross, spores germinate within phagocytes not in the extracellular 
spaces of the lungs.  However it has been shown in vitro that macrophages can induce 
germination without direct contact with the spores (Weiner and Hanna 2003; Gut, 
Tamilselvam et al. 2011).  The ability of cell-free conditioned media to induce 
germination is heat stable, but is lost following dialysis suggesting that this phenotype 
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maybe caused by the release of small molecule germinants supplied by the macrophages 
themselves.  
 
Virulence Factors 
Following germination within a suitable host, B. anthracis employs three primary 
virulence factors, two A/B-type toxins, and a poly-D-glutamic acid capsule.  Toxins and 
capsule are required to initiate and sustain disease (Dixon, Meselson et al. 1999).  Genes 
encoding the subunits of lethal toxin and edema toxin are encoded on the plasmid pXO1 
(Okinaka, Cloud et al. 1999).  The plasmid pXO2 contains a biosynthetic operon that is 
responsible for capsule production (Pannucci, Okinaka et al. 2002).  Both plasmids are 
required for full virulence, however the Sterne 34F2 strain of B. anthracis which lacks 
pXO2, has been shown to retain the ability to cause disease in several strains of inbred 
mice (Welkos, Keener et al. 1986; Welkos and Friedlander 1988). 
Anthrax toxins are composed of three exotoxin components, lethal factor (LF), 
edema factor (EF) and protective antigen (PA).  These components combine to form two 
A/B-type toxins, lethal toxin and edema toxin (Ascenzi, Visca et al. 2002).  A/B-type 
toxins have two functional subunits, an A moiety that is active once inside the cell, and a 
B moiety that is responsible for cellular recognition and binding.  For both lethal toxin 
and edema toxin, PA serves as the B subunit.  Once PA is bound to one of two cellular 
receptors located on the cell surface, it is proteolytically cleaved (Beauregard, Collier et 
al. 2000).  Cleavage of PA induces multimerization of the carboxy-terminal fragment on 
the cell surface and signals binding of LF, EF, or a combination of the two (Mogridge, 
Mourez et al. 2001).  The final toxin complex of seven cleaved PA fragments and three 
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LF or EF subunits is then endocytosed.  Endosome acidification leads to a conformational 
change in PA and the release of the LF or EF subunits into the cytosol where they are 
active (Petosa, Collier et al. 1997; Mogridge, Mourez et al. 2001).   
LF is a zinc-metalloprotease that targets mitogen-activated protein kinases 
(Duesbery, Webb et al. 1998).  Mitogen-activated protein kinases are important for 
signaling between the cell surface and the nucleus (Chang and Karin 2001).   In this way, 
LF alters normal gene expression in the nucleus of host macrophages impairing proper 
innate and adaptive immune responses and triggering the release of inflammatory 
cytokines that contribute to pathogenesis in the later stages of infection (Hanna, Kochi et 
al. 1992; Hanna, Acosta et al. 1993; Hanna, Kruskal et al. 1994; Vitale, Pellizzari et al. 
1998).  EF is a calmodulin-dependent adenylate cyclase that causes increased levels of 
cyclic AMP and subsequent edema due to the resulting imbalance of water homeostasis 
within the cell (Leppla 1982).  EF can also disrupt the ability of neutrophils to 
phagocytose B. anthracis cells (O'Brien, Friedlander et al. 1985). 
The pXO2 virulence plasmid encodes a biosynthetic operon, capBCDAE, required 
for the synthesis of a poly-D-glutamic acid capsule that surrounds the bacillus (Green, 
Battisti et al. 1985; Uchida, Sekizaki et al. 1985; Makino, Sasakawa et al. 1988; Makino, 
Uchida et al. 1989).  CapB, CapC, CapA, and CapE are required for capsule synthesis 
while CapD is responsible for covalently linking the capsule to the cell wall 
peptidoglycan (Candela and Fouet 2005; Candela, Mock et al. 2005).  The primary role 
of the capsule during infection is to protect the bacillus from phagocytosis (Drysdale, 
Heninger et al. 2005).   
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Sporulation and Spore Structure 
 Sporulation is the process by which vegetative cells return to the dormant spore 
phase of the bacterium.  This process is initiated when bacterial cells recognize that the 
nutrient supply in their environment has been exhausted, as is the case for B. anthracis 
following host death.  These environmental signals trigger a complex phosphorelay 
system that culminates in the phosphorylation of the master sporulation regulator Spo0A 
(Stragier and Losick 1996).  Phosphorylation of Spo0A activates transcription of several 
genes required for inducing an asymmetrical cell division (Figure 1.2A).  This results in 
two distinct compartments, the mother cell and the forespore, in which a temporally 
controlled cascade of compartment specific sigma factors is responsible for proper 
transcriptional regulation during sporulation (Stragier and Losick 1996). 
 Shortly after the asymmetrical septation is formed, the early forespore specific 
sigma factor, σF, is activated which in turn activates the early mother cell-specific sigma 
factor, σE (Figure 1.2B) (Margolis, Driks et al. 1991; Harry, Pogliano et al. 1995; Webb, 
Decatur et al. 1995).  Gene expression controlled by σF and σE leads to engulfment of the 
forespore by the mother cell, creating a double membrane “cell-within-a-cell” structure 
(Figure 1.2C) (Piggot, Moran et al. 1994).  As spore development continues, proteins 
from σG dependent genes expressed in the forespore are deposited from within while 
proteins from σK dependent genes are translated in the mother cell and deposited on the 
developing spore from the outside (Figure 1.2D) (Stragier and Losick 1996).  When spore 
development is complete, the mother cell is degraded and a fully developed spore is 
released (Figure 1.2E).   
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Figure 1.2: Bacillus sporulation.   
(A) Sporulation begins with the formation of an asymmetric septum and subsequent 
asymmetric cell division.  (B-C) Forespore specific gene expression is controlled by σF 
and mother cell gene expression is controlled by σE leading to engulfment of the 
forespore by the mother cell and the formation of a cell-within-a-cell structure.  (D) As 
the spore develops, proteins are deposited from within by genes under control of a 
forespore specific sigma factor and from the outside by genes controlled by a mother cell 
specific sigma factor.  (E) At the end of sporulation, the mother cell is degraded and one 
mature spore is released.  Figure adapted from a review by Stragier and Losick (Stragier 
and Losick 1996). 
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 Figure 1.3A diagrams the important structural features of a B. anthracis spore.  At 
the center is the core, which houses the genetic material.  The spore core exists in a 
highly dehydrated state (30-60% of the water content in a dividing cell).  Much of the 
water has been replaced by a 1:1 chelate of Ca2+ ions and dipicolinic acid (DPA) (Setlow 
2007).  Dehydration of the core and the presence of DPA are critical for spore resistance 
to wet heat (Setlow, Atluri et al. 2006).  The core is contained by the inner membrane, 
within which the germinant receptors are located (Sakae, Yasuda et al. 1995).  B. 
anthracis germinant receptors detect host-specific molecules (germinants) and 
subsequently trigger the process of germination.  The process of germination will be 
discussed in greater detail in a later section.   
Two layers of peptidoglycan, the germ cell wall and the cortex, surround the inner 
membrane.  The germ cell wall is derived from the cell wall of the forespore and will be 
the basis of the cell wall in the vegetative bacillus following germination.  The cortex is a 
much thicker layer of modified peptidoglycan (~80% of total peptidoglycan in a spore).  
In cortex peptidoglycan, 50% of the N-acetylmuramic acid residues (alternating every 
other residue along the polymer), are converted to a muramic-δ-lactam residues (Figure 
1.3B) (Popham 2002).  This modification is essential for specific degradation of the 
cortex by germination-specific lytic enzymes (GSLEs) during germination (Popham, 
Helin et al. 1996).  The cortex is required for full core dehydration (Henriques and Moran 
2007).   
Surrounding the cortex are the spore coats and the exosporium.  The composition 
of the spore coats and the presence or absence of the exosporium varies between spore-
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forming species (Aronson and Fitz-James 1976; Giorno, Bozue et al. 2007; Henriques 
and Moran 2007).  A combination of studies using DNA arrays and proteomic 
approaches have identified many of the proteins assembled into the spore coats (Kuwana, 
Kasahara et al. 2002; Lai, Phadke et al. 2003; Liu, Bergman et al. 2004; Giorno, Bozue et 
al. 2007; Henriques and Moran 2007).  While the majority of coat proteins identified in 
B. subtilis are shared with members of the B. cereus group including B. anthracis, there is 
relatively little overlap with the coat protein profile of Clostridium species (Henriques 
and Moran 2007). 
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Figure 1.3: Diagram of important spore structures.   
(A) Cross section of a B. anthracis spore and cartoon diagram of that same spore.  Spores 
fixed in 4% paraformaldehyde and ultra-thin sectioned. The sections were examined 
using a Philips CM100 electron microscope at 60kV.  (B) Chemical structure of cortex 
peptidoglycan and cell wall peptidoglycan polysaccharides.  Every other NAM residue is 
modified to a muramic-δ-lactam residue.  This modification results in reduced cross-
linking in cortex peptidoglycan.  NAG: N-acetyl glucosamine, NAM: N-acetyl muramic 
acid 
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Germination 
Overview 
 Figure 1.4 diagrams the sequential steps of spore germination in B. anthracis.  
Germination is initiated by the recognition of appropriate germinants by germinant 
receptor complexes found on the inner membrane of the spore.  Receptor-ligand 
interaction leads to the onset of stage-I germination by an unknown signaling pathway.  
At this time, it is believed that channels spanning the spore membranes, peptidoglycan 
and coats are opened and core rehydration begins.  As water rushes into the spore core, 
stores of DPA and cations flow out.  Partial core rehydration and release of Ca2+ and 
DPA initiate stage-II germination.  In this stage, germination-specific lytic enzymes 
located in the cortex and coat are activated and the cortex peptidoglycan is hydrolyzed.  
Degradation of the cortex allows for full core rehydration.  After the core is fully 
rehydrated, genetic and metabolic processes resume and the bacterium is able to outgrow 
and return to its vegetative state. 
 
Germinant Recognition 
Upon entry into the host, germination of dormant spores is dependent upon an 
appropriate germinant/germinant receptor interaction (Moir, Lafferty et al. 1979; 
Sammons, Moir et al. 1981; Zuberi, Moir et al. 1987; Corfe, Sammons et al. 1994; Ross 
and Abel-Santos 2010).  These interactions allow for both sensitive and ongoing 
environmental “sensing” by the dormant spore and trigger a very rapid return to 
vegetative growth, even after very extended periods of dormancy, when environmental 
conditions are favorable.  Germinant receptors localize to the spore inner membrane,  
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Figure 1.4: Steps of B. anthracis germination.  
Germination begins with the recognition of nutrient germinants by germinant receptors 
located on the inner membrane of the spore.  Ligand binding by the germinant receptors 
triggers the opening of channels in the spore that allow water to rush in and DPA, Ca2+ 
and other cations to flow out.  Partial core rehydration and Ca2+/DPA release signal the 
activation of GSLEs in the cortex.  Cortex degradation by GSLEs allows full core 
rehydration and outgrowth resulting in a vegetative bacillus. 
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where they sense the presence of discrete germinant signals in their environment.  The 
presence of germinants triggers an irreversible cascade of physical and biochemical 
changes, leading to the outgrowth of a metabolically active bacillus, with the ability to 
cause disease in the host (Stewart, Johnstone et al. 1981).   
Germinant receptors were first identified in B. subtilis, which encodes three, 
GerA, GerB, and GerK (Sammons, Moir et al. 1981).  As first shown in B. subtilis, the 
germinant receptors of all Bacillus species studied are encoded by tricistronic operons 
under the control of a σG promoter (Feavers, Foulkes et al. 1990; Corfe, Moir et al. 1994; 
Liu, Bergman et al. 2004).  These receptors respond to different defined germinants, and 
disruption of these receptors results in the inability to respond to those germinants 
(Sammons, Moir et al. 1981; Corfe, Sammons et al. 1994; McCann, Robinson et al. 
1996).  
The B. anthracis chromosome encodes four known functional germinant receptor 
operons, gerH, gerK, gerL, and gerS (Ireland and Hanna 2002; Read, Peterson et al. 
2003; Weiner, Read et al. 2003; Fisher and Hanna 2005).  An additional putative receptor 
operon, gerX, is encoded on the pXO1 virulence plasmid, although its function remains to 
be elucidated (Read, Peterson et al. 2003).  Mutational analyses indicate that at least one 
germinant receptor must be present to initiate disease in a murine model of anthrax 
infection, although there are some differences in receptor specificity depending upon 
route of infection (Carr, Lybarger et al. 2010).   Two additional receptor-like operons, 
gerA and gerY, were identified on the chromosome, but are unlikely to play a role in 
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germination, as these open reading frames contain frame-shift mutations (Read, Peterson 
et al. 2003; Fisher and Hanna 2005).  
The five receptors of B. anthracis have distinct germinant requirements, although 
redundancy and promiscuity exists between them.  Germinants consist of a primary 
germinant paired with a secondary co-germinant.  The primary germinant is either a 
purine nucleoside (typically adenosine or inosine) or L-alanine. The secondary co-
germinant is one of several L-amino acids.  These include L-alanine, L-serine, L-valine, 
L- histidine, L-methionine, L-proline, and L-tryptophan (Ireland and Hanna 2002; 
Weiner, Read et al. 2003; Fisher and Hanna 2005).  At high concentrations, L-alanine can 
also germinate spores in the absence of an additional germinant.  Inosine however, 
requires the co-stimulation provided by the L-amino acid co-germinant, although the 
mechanism behind this process is not yet clear (Ireland and Hanna 2002; Weiner, Read et 
al. 2003; Fisher and Hanna 2005; Carr, Lybarger et al. 2010).  
Although it was previously thought that B. anthracis germination required at least 
two germinant receptors, evidence now shows that individual germinant receptors can 
respond to germinants independently (Carr, Lybarger et al. 2010).  In an inhalational 
model of infection, the presence of any one of the chromosomally encoded receptors 
(GerH, GerK, GerL, or GerS) was enough to elicit a fully virulent infection.  This 
suggests the presence of a wide range of germinants at the site of germination.  In 
contrast, full virulence following subcutaneous inoculation requires the presence of GerH 
(Carr, Lybarger et al. 2010).  These different receptor requirements suggest a possible 
explanation for the presence of so many different, yet partially overlapping, germinant 
specificities.  These receptors may function cooperatively in the complex germinant 
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environment of a mammalian host, resulting in accelerated germination. In fact, recent 
work in vitro has demonstrated that different germinant receptor pathways can either 
synergize or block each other depending on the germinants present (Luu, Akoachere et al. 
2011).  Additionally, the large range of germinant specificities could provide a wider 
range of hosts and infectious routes available to B. anthracis in order to optimize its 
ability to germinate and cause disease. 
 
Germination-Specific Lytic Enzymes 
 A critical step in the process of spore germination is the breakdown of the cortex. 
The cortex contributes greatly to the environmental resistance of the spore but in order 
for vegetative cell growth to begin it must be selectively broken down leaving the cell 
wall intact (Setlow 2006).  This is accomplished through the action of a group of 
enzymes known as Germination-Specific Lytic Enzymes (GSLEs).    Genes encoding 
GSLEs are expressed during sporulation (Popham 2002; Liu, Bergman et al. 2004).  As 
the spore is being formed, GSLEs are packaged into the outer spore layers but remain 
inactive (Moriyama, Fukuoka et al. 1999).  Spores in the environment may be subjected 
to an extended period of dormancy, possibly as long as several decades (Gest and 
Mandelstam 1987; Cano and Borucki 1995; Nicholson, Munakata et al. 2000).  GSLEs 
must remain silent during this dormant period to maintain the environmental resistance of 
the spore.  Therefore, tightly regulating the activity of these enzymes is critical for the 
viability of the spore, but the processes by which this is accomplished in various spore-
forming bacterial species remains largely a mystery.    For example, the GSLE SleB is 
packaged as an inactive proenzyme that is proteolytically cleaved during germination in 
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order to be activated in Clostridium perfringens as well as Bacillus megaterium (Foster 
and Johnstone 1988; Miyata, Moriyama et al. 1995; Moriyama, Fukuoka et al. 1999).  
However, homologs of this enzyme in Bacillus subtilis and Bacillus cereus are packaged 
in their active forms and do not require proteolytic processing for activation (Moriyama, 
Fukuoka et al. 1999).  The need for this type of processing in B. anthracis spores remains 
unknown.   
 One common feature of all characterized GSLEs is their ability to preferentially 
degrade cortex peptidoglycan over cell wall peptidoglycan.  This is accomplished through 
enzyme recognition of modifications in the sugar residues of the cortex.  Bacterial cell 
wall peptidoglycan is comprised of repeating subunits of the saccharides N-acetyl 
glucosamine and N-acetyl muramic acid (Figure 1.3B)(Atrih, Zöllner et al. 1996; 
Popham, Helin et al. 1996; Popham 2002).  These two sugars are linked in an alternating 
pattern to form chains.  Polysaccharide chains are then cross-linked by peptide side 
chains found on the N-acetyl muramic acid residues giving the peptidoglycan its 
structure.  In cortex peptidoglycan, 50% of the N-acetyl muramic acid residues are 
replaced by muramic δ-lactam residues (alternating every other residue) (Warth and 
Strominger 1969).   This modification is somehow recognized by active GSLEs allowing 
for preferential breakdown of the cortex.   
 In B. anthracis the process of cortex degradation involves four enzymes, SleB, 
CwlJ1, CwlJ2, and SleL (Lambert and Popham 2008; Giebel, Carr et al. 2009; Heffron, 
Lambert et al. 2010).  The enzymes SleB, CwlJ1 and CwlJ2 are predicted members of the 
group known as spore cortex lytic enzymes (SCLEs).  These enzymes degrade intact 
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peptidoglycan.  The enzyme SleL is a predicted member of the cortex fragment lytic 
enzyme (CFLE) family (Makino and Moriyama 2002).  
 SleB and CwlJ are the primary GSLEs involved in cortex degradation of Bacillus 
species.  In B. subtilis and B. anthracis the presence of at least one of these genes is 
required for efficient spore germination indicating that these enzymes have partially 
redundant roles (Chirakkal, O'Rourke et al. 2002; Giebel, Carr et al. 2009; Heffron, 
Lambert et al. 2010).  In both B. subtilis and B. anthracis the sleB gene is found in a 
bicistronic operon with the gene ypeB.  The specific function of ypeB is not known; 
however mutant spores lacking this gene do not contain SleB (Boland, Atrih et al. 2000).  
This suggests that YpeB is necessary for proper expression, localization or stability of the 
SleB protein.  B. anthracis, unlike the closely related B. subtilis, contains two homologs 
of cwlJ termed cwlJ-1 and cwlJ-2 (Heffron, Orsburn et al. 2009).  The B. anthracis gene 
cwlJ-1, like the single copy of cwlJ found in the other species, is located in a bicistronic 
operon with the gene gerQ.  Much as is the case for ypeB and sleB, the presence of gerQ 
is required for CwlJ function (Ragkousi, Eichenberger et al. 2003; Ragkousi and Setlow 
2004).  The unique cwlJ2, which is 63% identical to cwlJ1 at the amino acid level, is not 
found in an operon with a gerQ homolog.  
 There are conflicting reports suggesting that SleL acts as either a glucosaminidase 
(Chen, Fukuoka et al. 2000; Lambert and Popham 2008) or an epimerase (Chirakkal, 
O'Rourke et al. 2002).  B. anthracis mutants lacking SleL do not show defects in the 
speed with which they escape the cortex and initiate outgrowth suggesting that this 
enzyme is not required for cortex hydrolysis.  However, mutants lacking SleL do retain 
~65% more N-acetyl muramic acid than wild type spores.  This finding is consistent with 
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the role of SleL as a CFLE that acts on partially degraded peptidoglycan (Lambert and 
Popham 2008).  Presumably, cortex degradation, at a level sufficient for outgrowth, is 
carried out by other GSLEs such as SleB and CwlJ.  SleL then acts on the large 
peptidoglycan fragments produced by these enzymes, further refining them to smaller 
muropeptide subunits.  It is possible that this secondary processing of cortex degradation 
products plays a role in the interaction between B. anthracis spores and the host immune 
system during infection.  A second possibility is that additional processing is involved in 
signaling neighboring spores in the population to begin germination.  It has been shown 
that cell-free B. subtilis peptidoglycan fragments can act as a germinant for B. anthracis 
spores (Shah, Laaberki et al. 2008).  However, the relative efficacy of peptidoglycan 
fragments collected from sleB, cwlJ1 or sleL mutants to trigger this germination pathway 
has not been tested.   
 
Summary 
 The successful and timely germination of spores is the essential first step in the 
pathogenesis of anthrax.  Proper B. anthracis spore germination is a strictly regulated 
process that is programmed during sporulation and only triggered upon entry into a 
suitable host, possibly decades later.  This process requires coordination of both 
germinant receptors and germination-specific lytic enzymes. 
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Dissertation Project 
 The work discussed in this dissertation examines the various mechanisms of 
cortex degradation during B. anthracis spore germination.  The initial objectives of this 
research were to identify the specific activity of three GSLEs, SleB, CwlJ1 and CwlJ2, 
using B. anthracis strains with null mutations and to address the means by which these 
GSLEs remain silent in the dormant spore.  Chapter 2 describes experiments designed to 
determine which enzymes were required and which were sufficient for spore germination 
in vitro as well as in a mouse model of infection.  The role of SleB, CwlJ1 and CwlJ2 on 
germination kinetics and colony forming efficiency in vitro as well as their effects on 
LD50 and mean time to death in an animal model are described.  Unexpected in vivo 
results led to the discovery that more than the endogenous spore germination machinery 
may influence spore germination inside a host.  Chapter 3 details results demonstrating 
that host lysozyme interacts with B. anthracis spores within the lungs.  These findings 
represent a new level of biological complexity in the events leading up to a B. anthracis 
infection.  Initial efforts and future studies intended to identify the means of GSLE 
silencing in a dormant spore are described in Chapter 4.  The findings produced by this 
dissertation shed new light on the critical step of cortex degradation during germination.  
A better understanding of this critical step in spore germination and subsequent disease is 
necessary for future development of anthrax therapeutics that target GSLE activity.  
Additionally they outline a previously unappreciated mechanism for spore germination in 
vivo that may prove to be integral to the pathogenesis of other spore-forming bacteria. 
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Chapter II 
Germination-Specific Lytic Enzymes SleB, CwlJ1, and CwlJ2 each contribute to 
Bacillus anthracis Spore Germination and Virulence 
 
ABSTRACT 
Bacterial spore cortex is critical for spore stability and dormancy and must be 
hydrolyzed by germination-specific lytic enzymes (GSLEs) to allow complete 
germination and vegetative cell outgrowth.  I created in-frame deletions of three genes 
that encode GSLEs that have been shown to be active in Bacillus anthracis germination: 
sleB, cwlJ1 and cwlJ2.  Phenotypic analysis of individual null mutations showed that the 
removal of any individual gene was not sufficient to disrupt spore germination in nutrient 
rich media.  This indicates these genes have partially redundant functions.  Double and 
triple deletions of these genes resulted in more significant defects.  Although a small 
subset of ΔsleB/cwlJ1 spores germinate with wild-type kinetics, the overall population 
has a decrease in colony-forming efficiency of three orders of magnitude below wild-
type.  ΔsleB/cwlJ1/cwlJ2 spores are unable to complete germination in nutrient rich 
conditions in vitro.  Both ΔsleB/cwlJ1 and ΔsleB/cwlJ1/cwlJ2 spores are significantly 
attenuated but not completely devoid of virulence in a mouse model of inhalation 
anthrax.    Although unable to germinate in standard nutrient rich media, spores lacking 
SleB, CwlJ1 and CwlJ2 are able to germinate in whole blood and serum in vitro, which 
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may explain the persistent low levels of virulence observed in the mouse infections.  This 
work contributes to an understanding of GSLE activation and function during 
germination.  This information may provide useful therapeutic targets against the disease 
anthrax as well as insights into ways to induce the breakdown of the protective cortex 
layer facilitating easier decontamination of resistant spores.   
 29 
INTRODUCTION 
Bacillus anthracis, a gram-positive spore forming bacterium, is the causative 
agent of anthrax.  The dormant spore form is the infectious particle and produces three 
different forms of the disease depending on route of entry into a suitable host (Dixon, 
Meselson et al. 1999).  When spores enter through a skin lesion or are ingested, they 
cause cutaneous and gastrointestinal anthrax, respectively.  Spores entering through the 
lungs cause the most severe form of the disease, inhalation anthrax, which is often fatal 
even with aggressive antibiotic therapy (Albrink 1961; Dixon, Meselson et al. 1999; 
Tournier, Quesnel-Hellmann et al. 2007).  Because true pneumonias are rarely seen in 
victims, it is believed that inhaled spores do not germinate in the lung but are 
phagocytosed by alveolar macrophages and germinate intracellularly en route to the 
mediastinal lymph nodes leading to dissemination, septicemia, toxemia, and often death 
(Albrink 1961; Tournier, Quesnel-Hellmann et al. 2007).  It has been shown that the 
bacteria are able to germinate and multiply inside macrophages both in cell culture and in 
the lungs of challenged animals (Ross 1955; Ross 1957; Guidi-Rontani, Weber-Levy et 
al. 1999; Dixon, Fadl et al. 2000). 
 Independent of route of infection, spore germination inside a susceptible host is 
essential for disease.  The highly stable spore form of the bacteria can remain viable 
under harsh environmental conditions for many decades (Setlow 2003).  However, the 
spore is able to return to a rapidly dividing vegetative cell upon entry into a host and 
recognition of specific chemical signals, or germinants, through specialized germinant 
receptors (Setlow 2003).  The spore cortex, a thick layer of modified peptidoglycan (PG), 
contributes much of the spore’s environmental resistance as it is necessary to maintain 
 30 
dehydration of the spore core (Popham 2002).  This protective barrier is broken down 
following the activation of germination-specific lytic enzymes (GSLEs) allowing full 
core rehydration and cell outgrowth (Setlow 2003).   Experimentally, germination can 
also be triggered by non-germinant pathways such as lysozyme treatment, high pressure, 
exogenous Ca++/dipicolinic acid treatment, and cationic surfactants (Setlow 2003).  
Several of these treatments likely cause spore cortex hydrolysis, triggering spore 
germination.  This indicates the importance of cortex degradation in the spore 
germination process.   
 Bacterial cell wall PG consists of polysaccharide chains of repeating N-acetyl 
glucosamine and N-acetyl muramic acid, joined by β(1,4) glycosidic bonds (Popham 
2002).  This basic structure is modified in several ways to form spore cortex PG.  In one 
major modification, 50% of muramic acid residues (alternating every other amino sugar) 
are converted to muramic-δ-lactam residues (Popham 2002).  This modification is 
essential for specificity of GSLEs in degrading the cortex, and prevents degradation of 
the bacterial cell wall during cortex hydrolysis (Moir, Corfe et al. 2002).   
 Previous work on the role of GSLEs in B. subtilis, and recently in B. anthracis, 
has shown that the enzymes SleB and CwlJ serve partially redundant roles and are 
necessary together for full cortex hydrolysis and spore germination (Chirakkal, O'Rourke 
et al. 2002; Heffron, Orsburn et al. 2009).  SleB is a lytic transglycosylase that when 
activated, by an unknown mechanism, hydrolyzes the bond between N-acetyl muramic 
acid and N-acetyl glucosamine (Boland, Atrih et al. 2000).  In both B. subtilis and B. 
anthracis, the gene sleB is found in a bicistronic operon with ypeB.  Although the 
function of YpeB is not known, the deletion of ypeB prevents SleB activity in spore 
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germination, and sleB and ypeB mutants have similar phenotypes (Boland, Atrih et al. 
2000).  Expression of both gene products is necessary for the presence of SleB in the 
cortex and inner membrane of mature spores (Boland, Atrih et al. 2000; Atrih and Foster 
2001).   
Although no specific enzymatic activity has been attributed to CwlJ, it is required 
for full germination and it shares a homologous catalytic domain with SleB (Moir 2006).  
In B. subtilis and B. cereus, cwlJ is found in an operon with gerQ.  Similar to the 
previous finding that ypeB is necessary for functional SleB protein, gerQ is required for 
CwlJ activity (Ragkousi, Eichenberger et al. 2003).  The B. anthracis genome contains 
two homologs of cwlJ (termed cwlJ1 and cwlJ2 (Heffron, Orsburn et al. 2009)) compared 
to the single copy found in B. subtilis and B. cereus.  As in the related species, cwlJ1 is 
found in an operon with gerQ, but cwlJ2 is in a different locus and is not in an operon 
with a gerQ homolog (Heffron, Orsburn et al. 2009).  It has been shown that CwlJ is 
localized to the spore coat and that it is necessary for spore germination by exogenous 
Ca++/DPA treatment (Paidhungat, Ragkousi et al. 2001; Bagyan and Setlow 2002).   
 GSLE activation represents a critical step in the complex process of germination.  
The relatively small number of genes involved and the apparent essential nature of their 
activity make them attractive targets for new therapeutics as well as environmental 
decontamination compounds.  The objective of this study was to test by genetic analysis 
the role of the GSLEs sleB, cwlJ1, and cwlJ2, in B. anthracis spore germination.  Null 
mutants of these three genes were tested for effects on in vitro germination kinetics and 
colony-forming efficiency.  Additionally, the virulence of these mutant strains was 
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examined by comparing mutant and wild-type spores in an in vivo mouse model of 
inhalational anthrax.   
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MATERIALS AND METHODS 
Bacterial strains and antibiotics 
 Bacterial strains and plasmids used in this study are listed in Table 2.1.   
Vegetative B. anthracis cultures were grown in brain-heart infusion media (BHI, Difco), 
and Escherichia coli cultures were grown in Luria-Bertani (LB) medium (Sambrook and 
Russell 2001).  All media were supplemented with the following antibiotics and 
concentrations to maintain selection as described in the mutant construction section: 
ampicillin (100 µg/ml), erythromycin (400 µg/ml for E. coli and 5 µg/ml for B. 
anthracis), kanamycin (10 µg/ml), polymyxin B (60 units/ml), spectinomycin (100 
µg/ml), and tetracycline (10 µg/ml).   
 B. anthracis spore stocks were prepared as previously described (Kim and 
Goepfert 1974; Dixon, Fadl et al. 2000).  Briefly, vegetative cells were diluted 1:100 in 
modified G medium (0.2% yeast extract, 0.17 mM CaCl2, 2.87 mM K2HPO4, 0.81 mM 
MgSO4, 0.24 mM MnSO4, 17 µM ZnSO4, 20 µM CuSO4, 1.8 µM FeSO4, 15.5 mM 
(NH4)2SO4, pH 7.2) and allowed to incubate at 37oC and 300 RPM for 72 hours.  
Following incubation, cultures were checked microscopically to verify presence of phase-
bright spores.  Spores were purified as previously described and the final stock was >99% 
phase-bright spore particles (Liu, Bergman et al. 2004).   
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Table 2.1: Bacillus anthracis strains and plasmids used in this study. 
 
Strain Relevant Characteristics Reference 
Sterne 34F2 Wild-type (pXO1+, pXO2-) (Sterne 1939) 
KC61 34F2, ΔsleB This work 
KC62 34F2, ΔypeB This work 
KC63 34F2, ΔsleB ΔypeB This work 
JG48 34F2, ΔcwlJ1 This work 
JG49 34F2, ΔcwlJ2 This work 
JG50 34F2, ΔsleB ΔypeB ΔcwlJ1 This work 
JG51 34F2, ΔsleB ΔypeB ΔcwlJ2 This work 
JG52 34F2, ΔcwlJ1 ΔcwlJ2 This work 
JG53 34F2, ΔsleB ΔypeB ΔcwlJ1 ΔcwlJ2 This work 
 
Plasmids Relevant Characteristics Reference 
pBKJ236 Allelic exchange vector, Emr (Janes and Stibitz 2006) 
pBKJ258 Allelic exchange vector, Kanr (Lee, Janes et al. 2007) 
pBKJ223 Tetr, Pamy I-SceI (Janes and Stibitz 2006) 
pJDG101 ΔsleB construct cloned in pBKJ258 This work 
pJDG102 ΔypeB construct cloned in pBKJ258 This work 
pJDG103 ΔcwlJ1 construct cloned in pBKJ236 This work 
pJDG104 ΔcwlJ2 construct cloned in pBKJ258 This work 
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 Mutant bacterial strains were constructed using the allelic exchange method as 
previously described (Janes and Stibitz 2006; Lee, Janes et al. 2007).  Allelic exchange 
plasmids were constructed as described for the ΔGBAA1941 construct (Bergman, 
Anderson et al. 2006).  For each gene deleted the initial 30 nucleotides were fused to the 
final 30 nucleotides creating an in frame deletion.  In place of the deleted genetic 
material, three stop codons were inserted into each gene.  CwlJ1 and cwlJ2 single 
mutants were constructed in a wild-type Sterne 34F2 background.  The ΔsleB mutant was 
made by removal of the ΔsleB/ypeB operon in a Sterne 34F2 background.  YpeB is 
proposed to act in either stability or targeting of sleB.  Both proteins are required for SleB 
activity and there is no phenotypic difference between ΔsleB and ΔypeB single mutants in 
the assays presented here (data not shown).  Double and triple mutant combinations were 
created by deletion of additional genes in the single mutant backgrounds.  All 
oligonucleotide sequences used in the construction and screening of mutant strains are 
available upon request. 
Germination Assays 
 Spore germination was measured by loss of heat sensitivity or decrease in optical 
density at 600 nm.  To measure loss of heat sensitivity, spore stocks were diluted to 
approximately 4x105 spores/ml and heat activated by incubation at 65oC for 20 minutes.  
Germination was initiated by adding 10 µl of spores to 2.0 ml of germination medium.  
At each time point (2, 5, 10, 15, 20, and 30 minutes) 100 µl aliquots of this solution were 
removed, incubated at 65oC for 20 minutes, then 50 µl was plated onto BHI agar and 
incubated overnight.  Colonies that formed represented spores that failed to germinate 
and were therefore heat resistant.  As a control, 50 µl of spores at time 0 were plated 
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without heat treatment.  The fraction of germinated spores for each time point was 
calculated as (1-tn)/t0 and reported as a percentage.  To assay decrease in optical density, 
5.0 ml of spores, OD600nm=0.6, were heat activated by incubation at 65oC for 20 minutes.  
Germinants were then added for a starting OD600nm of approximately 0.3 and the reaction 
was incubated at 37oC while shaking at 300 RPM.  At 5 minute intervals, 1.0 ml aliquots 
were removed and OD600nm was measured using a Genesys 10UV spectrophotometer 
(Spectronic Unicam, Rochester, NY). 
 The germination media used in this study were BHI (Difco), whole bovine blood 
(HemoStat Laboratories), and bovine serum.  Bovine serum was collected by pelleting 
whole blood at 4,000 RPM in an eppendorf 5810 R swinging bucket centrifuge.  
Following centrifugation, serum was filtered through a 0.2 µm syringe filter (Nalgene) 
and stored at 4oC.  Heat-treated serum was incubated at 65oC for 30 minutes. 
 In this study, colony-forming efficiency is defined as the number of spore 
particles that represent one cfu.  An improved Neubauer haemocytometer was used to 
assay spore particles per ml for each stock assayed.  The same spore stock was 
germinated in one of the germination media listed above for 10 minutes at 37oC.  
Germination reactions were then titered on BHI plates to measure cfu/ml.  
Murine Challenges 
 Intratracheal infections of DBA/2J mice (Jackson Laboratories) were done as 
previously described (Heffernan, Thomason et al. 2007).  Groups of eight mice were 
infected with doses ranging between 1.5x103 and 1.5x107 spores per mouse of mutant or 
wild-type strains.  Mice were monitored for a period of 14 days.  B. anthracis bacteria 
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was recovered from blood, spleen, heart, and lungs of randomly selected individuals that 
died following infection.  The strain identity was verified by diagnostic PCR.   
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RESULTS 
Effects of GSLE mutations on in vitro spore germination in BHI.   Germination 
appears to be a well-conserved process among spore forming bacteria including B. 
subtilis and B. cereus (Moriyama, Kudoh et al. 1996; Ishikawa, Yamane et al. 1998; 
Atrih and Foster 2001).  Independently, and using different assays than those presented in 
this study, Heffron et al.. (Heffron, Orsburn et al. 2009) have shown that single deletion 
mutations of the GSLEs sleB, cwlJ1 and cwlJ2 in B. anthracis, cause minor deficiencies 
in in vitro germination kinetics when compared to wild-type spores, and that the double 
mutant ΔsleB/cwlJ1 has severe germination deficiencies.  I had simultaneously 
constructed defined in-frame deletion mutations in each of the three GSLEs individually 
and in double and triple combinations to better determine the contributions of these three 
genes to spore germination in vitro and to determine if these genes play a role in 
virulence in an in vivo mouse model of inhalation anthrax. 
 No strains constructed exhibited a gross defect in sporulation or vegetative growth 
rates (data not shown).  These strains were germinated in vitro using BHI as a germinant 
and germination was monitored as loss of heat resistance (Fisher and Hanna 2005).  All 
single mutants reached ~100% germination in roughly the same time period, 2-5 min 
(Figure 2.1A).  Small variations in germination rates were observed from 0-5 min 
including slight delays by ΔcwlJ1 and ΔcwlJ2 at the 5 min time point and a temporary 
increase in the germination kinetics of ΔsleB at the 2 min time point.  Measuring spore 
germination by loss of heat resistance is limited in that it can only score viable spores that 
are ultimately able to outgrow.  Therefore I also measured germination by monitoring the 
drop in optical density at 600 nm, following the addition of germinants.  A decrease of 
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60% of the initial optical density is considered 100% germination (Nicholson and Setlow 
1990).  The ΔsleB and ΔcwlJ2 mutants did not reach 100% germination (Figure 2.1B).  
The ΔcwlJ1 mutant did reach 100% germination but was slightly delayed compared to 
wild-type (Figure 2.1B).  These results indicate that loss of any one GSLE only caused 
minor deficiencies in the germination kinetics compared to wild-type.   
 Germination of double mutants in BHI also showed small fluctuations in 
germination kinetics when measured by loss of heat resistance (Figure 2.1C).  Spores of 
the strain ΔsleB/cwlJ2 germinated with near wild-type kinetics.  Spores of the strain 
ΔcwlJ1/cwlJ2 had a delay in germination at the 5 minute time point when compared to 
wild-type spores.  Despite this delay, mutant spores still reached nearly 100% 
germination by the end of the 30 min time course.  Similarly, I found only minor 
germination defects in ΔsleB/cwlJ1 spores compared to wild-type.  As seen in the ΔsleB 
single mutant, spores of this double mutant were accelerated after 2 minutes but 
otherwise germinated in BHI in a manner similar to wild-type germination kinetics 
(Figure 2.1C).  However, as seen by Heffron et al. (Heffron, Orsburn et al. 2009), I found 
severe defects in ΔsleB/cwlJ1 and additionally in ΔsleB/cwlJ1/cwlJ2 spore germination 
when measured by drop in optical density (Figure 2.1D).  Although the drop in optical 
density assay is better able to detect early events in spore germination, small subsets of 
spores will be lost in the background of the population.  I believe that this explains the 
different results for ΔsleB/cwlJ1 spore germination when measured by the two different 
methods.  Although the ΔsleB/cwlJ1 spore population as a whole has major germination 
defects and cannot outgrow, the small number of spores that do outgrow germinate with 
wild-type kinetics (Figure 2.1C-D). 
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Figure 2.1: In vitro germination of spores in BHI.   
Loss of heat resistance (A and C) and drop in OD600nm (B and D) were measured as 
markers of spore germination.  A 60% decrease in OD600nm is approximately 100% 
germination.  Spores were incubated in BHI at 37°C for 0-30 min. Germination kinetics 
of the triple mutant strain ΔsleB/cwlJ1/cwlJ2 could not be assayed by loss of heat 
resistance because this strain was unable to germinate in response to BHI.  All panels 
represent mean values from 2-3 independent experiments, error bars represent ±standard 
error. 
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Germination kinetics of the triple mutant strain ΔsleB/cwlJ1/cwlJ2 could not be 
assayed by loss of heat resistance because this strain was unable to germinate in response 
to BHI.  However, this mutant had the identical germination defect of ΔsleB/cwlJ1 spores 
when measured by drop in optical density (Figure 2.1D).  To better characterize the 
nature of this dramatic defect and to test if similar defects were present in the double 
mutant strains, colony-forming efficiency was measured for each strain.  I tested colony-
forming efficiency by visually quantifying the number of spores in a sample using a 
haemocytometer and then inducing germination of those same spores with a variety of 
germinants.  By comparing the difference between the concentration of a spore stock 
(spores/ml) when counted on a haemocytometer and the cfu/ml of the same stock when 
titered on BHI plates I determined the colony-forming efficiency of all double and triple 
GSLE mutants in nutrient rich media (Figure 2.2).  The colony-forming efficiency of 
ΔsleB/cwlJ1/cwlJ2 was found to be 8.2x107 spore particles per cfu, a decrease of seven 
orders of magnitude compared to wild-type spores.  Consistent with a recent report 
(Heffron, Orsburn et al. 2009), the strain ΔsleB/cwlJ1 also exhibited a significant 
decrease in colony-forming efficiency of approximately three orders of magnitude when 
compared to wild-type.  All other double mutants and wild-type strains yielded an 
approximate colony-forming efficiency of 1 (Figure 2.2).  These data show that although 
these GSLEs do not play a major role in germination kinetics, they are necessary for 
spore outgrowth.  Furthermore, it appears that all three genes have partially redundant 
functions as any one is sufficient for at least some level of colony-forming ability.  In 
order of increasing colony-forming efficiency, the triple mutant ΔsleB/cwlJ1/cwlJ2 had 
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the lowest colony forming efficiency followed by ΔsleB/cwlJ1.  The remaining strains 
ΔsleB/cwlJ2 and ΔcwlJ1/cwlJ2 had the highest colony-forming efficiency at levels 
comparable to wild-type.  This indicates that contributions from sleB and cwlJ1 have 
greater influence on colony-forming efficiency than cwlJ2.   
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Figure 2.2: Colony-forming efficiency of GSLE mutants.   
Colony-forming efficiency was examined by visually assaying the number of spores/ml 
(black bars) of a given stock as enumerated on an improved Neubauer haemocytometer 
and comparing that to cfu/ml (white bars) of that same stock when plated on BHI.  Data 
shown above is a representative sample of typical results from three independent 
experiments. 
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Virulence of GSLE mutant strains in mice.  Although the B. anthracis Sterne strain is 
attenuated in many mammalian species, certain strains of inbred mice including DBA/2J 
are susceptible to the bacteria making them an excellent model system for virulence 
studies (Welkos, Trotter et al. 1989; Harvill, Lee et al. 2005).  I used intratracheal 
injection of spores into the lungs as a model for inhalational anthrax (Fisher, Shetron-
Rama et al. 2006).  Virulence in DBA/2J mice when challenged with all double and triple 
mutants described above was compared to wild-type bacteria.  DBA/2J mice infected 
with wild-type spores had a median time to death of two days at a dose of 1.5x106 
spores/mouse and an LD50 of 1.5x104 spores/mouse (Table 2.2). 
 The ΔcwlJ1/cwlJ2 double mutant, which had a slight delay in germination 
kinetics in vitro (Figure 2.1C-D), showed no attenuation in virulence compared to wild-
type at a dose of 1.5x106 spores/mouse (100x the wild-type LD50) (Figure 2.3A), and no 
significant increase in median time to death (Table 2.2).  The ΔsleB/cwlJ2 double mutant 
strain, which showed the least amount of variation from wild-type germination kinetics in 
BHI, was slightly attenuated (Figure 2.3B) and had a slightly longer delay in median time 
to death (Table 2.2).  Although these values were not significantly different from wild-
type (p=0.058) they did trend away from wild-type spores.  As expected from the in vitro 
colony-forming efficiency, the strain ΔsleB/cwlJ1 exhibited a highly significant 
(p=0.0001) attenuation compared to wild-type spores (Figure 2.3C).  Median time to 
death of this strain was increased from 2 days with wild-type spores to 5.5 days, and even 
at a 10 fold higher dose (1.5X107 spores/mouse) a delay in median time to death was 
observed (2 days wild-type to 3.5 days mutant) compared to the lower dose of wild-type 
bacteria (Table 2.2).   
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Table 2.2: DBA/2J Mouse Virulence 
 Median Time to Death (days)  
 
Strain 1.5x106 spores 1.5x107 spores LD50** (spores/mouse) 
34F2 2 ND* 1.5 x 104 
ΔsleB/cwlJ1 5.5 3.5 1.2 x 106 
ΔsleB/cwlJ2 3.5 ND* ND* 
ΔcwlJ1/cwlJ2 3 ND* ND* 
ΔsleB/cwlJ1/cwlJ2 Undefined*** 4 8.3 x 106 
* ND: not determined 
**  LD50 calculations were done by Reed and Muench method (Reed and Muench 1938) 
and were based on survival data from 4 groups of mice (n=8) at 4 different doses for each 
of the strains assayed. 
*** Because only 2 out of 8 mice in the group died during the course of the experiment, 
the dose was not lethal enough to determine median time to death.   
 46 
 
 
 
 
 
 
 
 
Figure 2.3: Survival curves of GSLE mutants in mice.   
DBA/2J mice (n=8 mice per group) were challenged by intratracheal infection with WT 
() and mutant () spores at a dose of 1.5x106 spores/mouse.  The mice were monitored 
for 14 days at which point all surviving mice were euthanized.  Survival curves for 
ΔsleB/cwlJ1 (C) and ΔsleB/cwlJ1/cwlJ2 (D) were found to be significantly different from 
wild-type p=0.0001 and p=0.0005 respectively, by log-rank (Mantel-Cox) test.  Although 
not meeting the significance threshold, the ΔsleB/cwlJ2 (B) survival curve did show a 
trend away from wild-type (p=0.058). 
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 Next I tested the virulence of the ΔsleB/cwlJ1/cwlJ2 triple mutant in our mouse 
model.  The triple mutant was significantly attenuated (Figure 2.3D, p=0.0005), but it did 
retain some measure of virulence, killing 25% of mice challenged in 4 days.  This was 
somewhat surprising because the triple mutant was functionally unable to germinate in 
rich media.  On BHI plates, only one spore per 82 million could germinate.  As each 
mouse was given a dose of only 1.5 million spores, I did not expect to see any 
germination or subsequent mortality.  Necropsies were performed on a subset of animals 
that succumbed to the infection and mutant bacteria were isolated on BHI plates, 
confirming that mutant spores were able to geminate inside mice and multiply to near 
wild-type levels (data not shown).  Median time to death for this strain could not be 
determined at the same dose as the above listed strains (1.5x106 spores/mouse) because it 
was not virulent enough to kill at least half the mice challenged within the time course of 
the experiment (Table 2.2).  At a 10-fold higher dose, 1.5x107 spores/mouse, the median 
time to death was 4 days.  This was delayed compared to the lower dose of wild-type 
spores (2 days) but was approximately the same as the equally high dose of double 
mutant ΔsleB/cwlJ1 spores (3.5 days) (Table 2.2).  Although both are significantly 
attenuated compared to wild-type, the highest doses of ΔsleB/cwlJ1 and 
ΔsleB/cwlJ1/cwlJ2 tested, 1.5x107 spores/mouse and 8.4x107 spores/mouse respectively, 
did not produce significantly different survival curves and had the same median time to 
death, 3.5 days (data not shown).  This suggested that despite increasing numbers of 
mutant spores in the challenge dose, only a certain subset were able to germinate and 
cause disease.   
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 To further define the virulence effects of the attenuated mutants, LD50 values 
were determined for wild-type, ΔsleB/cwlJ1, and ΔsleB/cwlJ1/cwlJ2.  Groups of mice 
(n=8) were infected by intratracheal injection with 4 different doses of spores suspended 
in water.  The parental Sterne strain 34F2 (wild-type) had an LD50 of 1.5x104 spores.  
LD50 values of ΔsleB/cwlJ1 and ΔsleB/cwlJ1/cwlJ2 were found to be, 1.2x106 spores and 
8.3x106 spores respectively, or 80 fold and 550 fold higher than wild-type respectively 
(Table 2.2).  Taken together, these data show that lack of germination on nutrient rich 
media in vitro, does not indicate a block of germination in vivo, and that another 
mechanism of spore germination may be active in the host. 
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Effects of GSLE mutations on in vitro germination in blood.  Although it was 
expected that the colony-forming deficient mutant ΔsleB/cwlJ1 would be at least 
somewhat attenuated in mice, it did not seem likely that the extreme colony-forming 
deficient mutant ΔsleB/cwlJ1/cwlJ2 would retain any ability to cause disease.  Based 
solely on colony-forming units on BHI, even the highest challenge dose of 
ΔsleB/cwlJ1/cwlJ2 would be effectively 1 germinating spore/mouse, 10,000-fold lower 
than the wild-type LD50.  These data lead to the hypothesis that a host factor(s) was able 
to cause germination at levels higher than those calculated from using BHI as a germinant 
and perhaps circumvent the requirement for GSLE activities.   
To test if such factors were in blood, colony-forming efficiency assays were 
repeated with ΔsleB/cwlJ1/cwlJ2 spores using defibrinated bovine whole blood as the 
germination medium.  Spores were first incubated for 10 minutes in defibrinated bovine 
blood to initiate germination.  Then the spores were plated on BHI and allowed to 
outgrow at 37°C.  The colony-forming efficiency of ΔsleB/cwlJ1/cwlJ2 increased from 
8.2x107 spores per cfu when germinated in BHI to 9.2x103 spores per cfu when 
germinated in blood.  This represents an increase of almost 4 orders of magnitude over 
colony-forming efficiency in BHI (Figure 2.4).  Triple mutant colony-forming efficiency 
in blood was about 3 orders of magnitude below that of wild-type spores germinated in 
blood (data not shown). 
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Figure 2.4: In vitro germination of ΔsleB/cwlJ1/cwlJ2 spores in blood.   
Colony-forming efficiency of ΔsleB/cwlJ1/cwlJ2 spores in blood and serum was 
examined. Spore dilutions were quantified visually with an improved Neubauer 
haemocytometer (spores/ml) (black bar) and compared to cfu/ml (white bars) when 
spores were allowed to germinate in PBS (pH=7.5), brain heart infusion (BHI), whole 
bovine blood, bovine serum, or heat killed bovine serum for 10 min before being plated 
on BHI plates and incubated at 37oC overnight.   
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 Next I wanted to further examine the source of the host germination factor by 
removing the contribution of whole cells in the blood.  To do this, I used filtered bovine 
serum and heat-treated filtered bovine serum as germination media for triple mutant 
spores.  Mutant spores germinated in serum at a rate comparable to whole blood, 2.9x103 
spores per cfu in bovine serum compared to 9.2x103 spores per cfu in whole blood 
(Figure 2.4).  This indicates that serum contains all the necessary host components 
contained in whole blood to cause mutant spore germination and that whole cells in blood 
do not play a direct role. Bovine serum heat-treated at 65oC for 30 minutes lost the ability 
to cause germination in ΔsleB/cwlJ1/cwlJ2 spores (Figure 2.4).  This suggests that the 
host factor causing mutant-spore germination is heat labile and may be an enzyme in 
serum.    
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DISCUSSION  
 
 GSLEs are expressed during B. anthracis sporulation and are active during 
germination (Bergman, Anderson et al. 2006; Heffron, Orsburn et al. 2009).  Deletion of 
the genes that encode the enzymes SleB, CwlJ1, and CwlJ2, was sufficient to 
significantly disrupt spore germination and, in the case of the triple mutant, even lead to 
complete loss of germination in rich medium in vitro.  However, these germination-
deficient spores retained some virulence in our mouse model, suggesting an alternate 
mechanism of spore germination.   
 Individual deletions of the genes sleB, cwlJ1 and cwlJ2 did not cause major 
differences in germination kinetics or colony forming efficiency (Figure 2.1).  These 
mutants were not tested for virulence in mice.  The double mutants ΔsleB/cwlJ2 and 
ΔcwlJ1/cwlJ2 also only produced minor effects on germination kinetics and had no effect 
on colony-forming efficiency (Figs. 2.1-2).  However, the double mutant ΔsleB/cwlJ1 
was decreased by three orders of magnitude in colony-forming efficiency on BHI (Figure 
2).  Despite this defect, the small percentage of the spore population that was able to 
outgrow, germinated with kinetics very similar to wild-type spores (Figure 2.1C).  I 
believe the assay measuring a drop in optical density was not sensitive enough to detect 
the germination kinetics of the subpopulation of spores that managed to germinate.  
Because only outgrowing spores can be detected in the assay measuring loss of heat 
resistance, I was able to see that in fact the population defect was not uniform and that 
while the bulk of the spores are defective, a small number germinate like wild type.  The 
triple mutant ΔsleB/cwlJ1/cwlJ2 had a decrease of seven orders of magnitude in colony-
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forming efficiency in BHI compared to wild-type (Figure 2.2).  Because of this severe 
defect in germination, the germination kinetics of outgrowing spores could not be 
measured; however, the population exhibited the same severe defect as ΔsleB/cwlJ1 
spores when assayed by drop in optical density (Figure 2.1D).  
B. subtilis and other related species of spore-forming bacteria contain one copy of 
the gene cwlJ, while the B. anthracis genome contains a second copy referred to as cwlJ2 
(Chirakkal, O'Rourke et al. 2002; Heffron, Orsburn et al. 2009; Setlow, Peng et al. 2009). 
The single copy of cwlJ in other species, and the gene cwlJ1 in B. anthracis are found in 
an operon with gerQ, a gene that has been shown to be required for proper targeting of 
cwlJ in the developing forespore (Ragkousi, Eichenberger et al. 2003).  This conserved 
gene structure implies the relative importance of cwlJ1 over cwlJ2.  Mutations of cwlJ2 
show no major defect in colony-forming efficiency (Figure 2.2), suggesting that CwlJ2 is 
a less functional or redundant protein.  Although CwlJ2 does not appear to be the primary 
protein involved, it is active during germination and can compensate in the absence of 
CwlJ1.  The double mutant ΔcwlJ1/cwlJ2 has a greater germination defect than either of 
the single mutations (Figure 1).   Also, the triple mutant ΔsleB/cwlJ1/cwlJ2, has a 
100,000-fold decrease in colony forming ability compared to the double mutant 
ΔsleB/cwlJ1 in BHI (Figure 2.2).  These experiments show that SleB or CwlJ1 are 
sufficient for near wild-type levels of spore germination.  CwlJ2 is sufficient for low-
level germination, which can be observed when this protein is compensating for the 
absence of SleB and CwlJ1.   
 GSLEs play a critical role in the germination of all spore-forming bacteria, and it 
has long been thought that targeting the activity of these enzymes could provide useful 
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therapies.  The complete lack of in vitro germination of ΔsleB/cwlJ1/cwlJ2 supports this 
theory, but the continued virulence in a mouse model indicates that there are alternate 
mechanisms of germination that can result in disease.  I calculated the LD50 of wild-type 
Sterne 34F2 to be 1.5x104 spores/mouse in the DBA/2J mouse model.  Mutant strains 
ΔsleB/cwlJ1 and ΔsleB/cwlJ1/cwlJ2 were attenuated and had increased LD50s of 80-fold 
and 550-fold that of wild-type respectively (Table 2.2).  Despite an increase in LD50 and a 
large decrease in colony-forming efficiency for ΔsleB/cwlJ1/cwlJ2 compared to 
ΔsleB/cwlJ1, at no dose tested was there a significant difference in murine survival 
following infection with these two mutant strains (Figure 2.3 and data not shown).  This 
suggests that an alternate method of germination may involve limiting host factors in 
vivo.  It remains possible that these factors are host-specific germinants that activate 
unknown GSLEs.  However, it is much more likely that a host factor is able to 
complement missing GSLE functions.  These potential factors are unknown, and are 
currently under investigation.  They may include host enzymes with peptidoglycan 
hydrolyzing activity such as lysozyme.  The ability of ΔsleB/cwlJ1/cwlJ2 spores to 
germinate in bovine serum but not heat-treated bovine serum suggests the role of a host 
enzyme in germination and supports a host factor complementation mechanism (Figure 
4).  Interestingly, the triple mutant colony-forming efficiency in bovine serum is about 3 
orders of magnitude below that of wild-type (Figure 2.4) which is consistent with the 
550-fold decrease in LD50 between the triple mutant and the wild-type strain (Table 2.2).   
 It is generally believed that inhalation anthrax is the result of spore germination 
within alveolar macrophages (Ross 1957; Guidi-Rontani, Weber-Levy et al. 1999).   
Inhaled spores remain dormant in the lungs, possibly for many weeks, until they are 
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engulfed by lung macrophages and trafficked to the nearest lymph node. B. anthracis 
spores engulfed by macrophages are not killed, but undergo germination and replication 
within the cell until it is ruptured (Dixon, Fadl et al. 2000).  It would be interesting to 
know if the alternate germination mechanism provided by components of the serum was 
also active in alveolar macrophages. 
 SleB, CwlJ1, and to a lesser extent CwlJ2 enzymes play important roles in the 
successful germination and outgrowth of B. anthracis spores.  Removal of all three 
enzymes is sufficient to block in vitro germination under standard laboratory conditions.  
Continued virulence of these strains despite their lack of in vitro germination sheds new 
light on secondary, host-directed mechanisms of germination in vivo.  Although it is clear 
that many benefits in disease therapies and spore decontamination can come from 
targeting germination specific lytic enzymes, it will be important to understand and 
control these secondary factors to fully combat disease.    
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Chapter III 
Host lysozyme contributes to Bacillus anthracis spore germination in vivo. 
Abstract 
 Germination-specific lytic enzymes (GSLEs) are required for typical Bacillus 
anthracis spore germination.  Here I investigate the ability of lysozyme to complement 
GSLE activity in a B. anthracis mutant lacking sleB, cwlJ1 and cwlJ2 
(ΔsleB/cwlJ1/cwlJ2).   Germination of mutant spores was measured in vitro using 
nutrient rich medium (BHI), murine serum, and a solution of purified hen egg white 
lysozyme. ΔsleB/cwlJ1/cwlJ2 spore germination was readily detected in serum and in 
purified lysozyme but not in heat-treated serum.  This germination phenotype correlated 
with the presence of lysozyme activity in each sample.  Bone marrow-derived 
macrophages from wild-type mice were able to induce germination of ΔsleB/cwlJ1/cwlJ2 
spores while macrophages derived from lysozyme M-deficient mice could not.  Finally, 
Lysozyme M-/- mice were protected against infection with ΔsleB/cwlJ1/cwlJ2 spores 
compared to wild-type mice.  Spore germination is a critical step in the disease anthrax.  
Therefore GSLEs are attractive therapeutic targets.  This work increases our 
understanding of the interaction between B. anthracis spores and the host, specifically as 
it relates to cortex degradation and GSLE function during germination.   
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Introduction 
 During an inhalational anthrax infection, Bacillus anthracis spores are taken up 
into the alveolar spaces of the host lungs (Dixon, Meselson et al. 1999).  Here they are 
engulfed by macrophages or dendritic cells and the process of spore germination, a 
critical first step in disease initiation, begins (Ross 1957; Guidi-Rontani, Weber-Levy et 
al. 1999; Dixon, Fadl et al. 2000; Cleret, Quesnel-Hellmann et al. 2007).  The proteins 
required for germination, including those involved in host recognition, breaking down 
spore structures, and transitioning to vegetative cell growth, are prepackaged into 
endospores during sporulation (Kroos and Yu 2000; Liu, Bergman et al. 2004).  Once 
these proteins are activated, the germination process is irreversible (Foster and Johnstone 
1988).  While dormant, germinant receptor proteins located in the inner membrane of the 
spore passively sense the spore’s external environment (Moir, Corfe et al. 2002).  In B. 
anthracis spores, these receptors are activated by specific combinations of purine 
nucleosides, typically inosine, and L-amino acids (Carr, Lybarger et al. 2010).  
Activation of germinant receptors initiates stage I germination, during which channels are 
opened in the spore allowing partial core rehydration.  As water flows into the spore, 
cations and dipicolinic acid flow out (Moir, Corfe et al. 2002).  These events trigger stage 
II germination which involves the activation of germination-specific lytic enzymes 
(GSLEs) (Setlow 2003).  GSLEs hydrolyze peptidoglycan containing muramic-δ-lactam, 
a modified muramic acid residue found only in the spore cortex (Atrih, Zöllner et al. 
1996; Popham, Helin et al. 1996).  This modification allows for specific degradation of 
the cortex, leaving the germ cell wall peptidoglycan intact.  GSLEs must degrade the 
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spore cortex to allow full rehydration of the core and the transition to a vegetative 
bacillus (Setlow, Melly et al. 2001).   Since cortex breakdown and full core rehydration 
are required for normal enzymatic function, GSLE activation is a critical checkpoint 
during germination (Setlow, Melly et al. 2001). 
 B. anthracis germination involves the action of four GSLEs (Heffron, Orsburn et 
al. 2009).  Two of these enzymes, SleB and CwlJ1, are individually sufficient to complete 
germination (Giebel, Carr et al. 2009; Heffron, Lambert et al. 2010).  The two remaining 
enzymes, CwlJ2 and SleL, serve secondary roles in cortex degradation and cortex 
fragment modification (Lambert and Popham 2008; Giebel, Carr et al. 2009).  When the 
genes sleB, cwlJ1 and cwlJ2 are disrupted (ΔsleB/cwlJ1/cwlJ2), nutrient-induced spore 
germination as outlined above is abolished (Giebel, Carr et al. 2009).  When these mutant 
spores come into contact with traditional B. anthracis germinants, such as in the rich 
bacterial broth BHI, stage I germination events proceed normally (Giebel, Carr et al. 
2009).  However, in stage II germination, cortex degradation is blocked and the cells 
cannot complete core rehydration, which is necessary for transition to vegetative growth 
(Setlow, Melly et al. 2001).  I have previously shown that when ΔsleB/cwlJ1/cwlJ2 
spores are plated on BHI, only 1 in 80 million spores successfully germinate and 
subsequently multiply, creating a colony-forming unit (cfu) (Giebel, Carr et al. 2009).   
Since germination is essential to initiate disease, these in vitro findings would 
predict that ΔsleB/cwlJ1/cwlJ2 spores would be incapable of infecting and killing mice.  
However, DBA/2J mice are more susceptible to infection by this mutant than would be 
predicted by this in vitro germination rate.  The LD50 for DBA/2J mice infected with 
wild-type (34F2 Sterne strain) B. anthracis spores intratracheally is 15,000 spores/mouse, 
 59 
which based on the 1:1 colony-forming efficiency in wild-type B. anthracis represents 
15,000 cfu/mouse (Giebel, Carr et al. 2009).  However, when DBA/2J mice were infected 
with 1.5 million ΔsleB/cwlJ1/cwlJ2 spores, predicted to represent less than 1 cfu based on 
their severely decreased colony-forming rate, 25% of mice succumb to the infection.  
This suggests that spores within a mouse complete germination more efficiently than 
predicted, either by means of a previously unidentified GSLE or using a non-nutrient 
pathway.    
 B. anthracis spores are known to germinate in several nutrient-independent 
pathways including by exogenous lysozyme treatment (Setlow 2003).  Like native 
GSLEs, lysozyme hydrolyzes the β-1,4 glycosidic bond between N-acetylglucosamine 
and N-acetylmuramic acid (Ibrahim, Aoki et al. 2002).  Lysozyme treatment can induce 
germination in mutants that affect GSLE activity, and would likely be encountered by 
spores in vivo making it a likely candidate for increased ΔsleB/cwlJ1/cwlJ2 germination 
and virulence (Cross, Mangelsdorf et al. 1988; Sekiguchi, Akeo et al. 1995).  
Mutant spores of the related species, Bacillus subtilis, that lack the gene cwlD, fail to 
incorporate the muramic-δ-lactam modification in their cortex peptidoglycan (Popham, 
Helin et al. 1996).  Since this modification is required for GSLE recognition and activity, 
a cwlD mutant effectively prevents the action of all GSLEs.  In this case, loss of cwlD 
completely blocked colony formation much like the defect observed for 
ΔsleB/cwlJ1/cwlJ2 spores.  When cwlD spores were treated with lysozyme, a small 
percentage was able to germinate and grow, overcoming the loss of GSLE activity 
(Sekiguchi, Akeo et al. 1995). 
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 Lysozyme is expressed in a variety of tissues within a broad range of animals, 
including mice (Fleming 1922; Cross, Mangelsdorf et al. 1988).  Unlike humans, which 
express only one lysozyme gene, mice have evolved two genes that encode for this 
protein, lysozyme M and lysozyme P (Hammer, Schilling et al. 1987).  Lysozyme M is 
the most closely related to human lysozyme and is found in the majority of mouse tissues.  
In contrast, lysozyme P is predominantly expressed in the small intestine and may have 
evolved to function in digestion (Hammer, Schilling et al. 1987; Hammer and Wilson 
1987; Cross, Mangelsdorf et al. 1988).   Lysozyme M is the more relevant form of this 
protein to B. anthracis infections because it is abundant in the lungs, macrophages, and in 
serum, environments that spores encounter early in infection.  This protein has also been 
shown to function in host defense against bacterial infections (Cross, Mangelsdorf et al. 
1988; Akinbi, Epaud et al. 2000; Markart, Korfhagen et al. 2004).  During a laboratory 
challenge, ΔsleB/cwlJ1/cwlJ2 spores injected into the lungs would immediately encounter 
lysozyme M secreted onto the airway surface by lung epithelial cells.  Spores would also 
be exposed to high concentrations of lysozyme M after being phagocytosed by alveolar 
macrophages, as is predicted at the onset of a typical anthrax infection.  Because it has 
been shown that lysozyme can induce spore germination in a nutrient independent 
manner and that spores inoculated intratracheally will repeatedly encounter host 
lysozyme, I set out to test the hypothesis that lysozyme-induced germination leads to 
increased virulence in ΔsleB/cwlJ1/cwlJ2 infection.  In this study, I test the ability of 
murine serum and purified lysozyme to induce ΔsleB/cwlJ1/cwlJ2 spore germination in 
vitro, as well as the role of lysozyme M during experimental infections.   
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Materials and Methods 
Bacterial culture conditions and spore preparation 
 B. anthracis strain 34F2:ΔsleB/cwlJ1/cwlJ2 (Giebel, Carr et al. 2009) was cultured 
in brain heart infusion medium (BHI) (Difco) and colony-forming units were titered on 
BHI plus 1.5% agarose plates.  Spore stocks were prepared as previously described (Kim 
and Goepfert 1974; Dixon, Fadl et al. 2000).  Briefly, actively dividing vegetative cells, 
taken from a log-phase culture, were diluted 1:100 in modified G medium (0.2% yeast 
extract, 0.17 mM CaCl2, 2.87 mM K2HPO4, 0.81 mM MgSO4, 0.24 mM MnSO4, 17 µM 
ZnCl2, 20 µM CuSO4, 1.8 µM FeCl3, 15.5 mM (NH4)2SO4, pH 7.2) and incubated at 
37oC and 300 RPM for 72 hours.  Following incubation, cultures were observed 
microscopically to verify the presence of phase-bright spores.  Spores were purified by 
washing three times in sterile deionized H2O and passage through a 3.1 micron filter 
(National Scientific Company, part #F2500-20).  Following filtration, spore suspensions 
were heat treated at 65 oC for 20 minutes to kill any remaining vegetative bacilli.   
Germination assays and lysozyme activity assays 
Colony-forming efficiency is defined as the number of spore particles that 
represent one cfu.  An improved Neubauer haemocytometer was used to assay spore 
particles per milliliter.  2x106 spore particles were incubated in each germinant for 10 
minutes at 37 oC.  The entire reaction was plated on BHI to determine cfu/ml.  
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Germinants that were assayed included 10 µg/ml HEWL (Sigma), mouse serum (MP 
Biomedicals), and BHI.  Lysozyme activity was measured using the EnzChek Lysozyme 
Assay Kit (Molecular Probes) according to the manufacturer’s protocols and 
recommendations.  
Mouse strains and virulence assays 
 Lysozyme M deficient mice were generated by inserting the enhanced green 
fluorescent protein gene in exon 1 of the lysozyme M gene resulting in a null mutation. 
The mice are indistinguishable from WT mice. Characterization of the lysozyme M-/- has 
been previously reported (Faust, Varas et al. 2000; Markart, Faust et al. 2004). The mice 
were backcrossed to FVB/N through 10 generations. For all experiments, age- and sex-
matched WT FVB/N were used as controls.  
Intratracheal infections of wild-type and lysozyme M-/- mice were conducted as 
previously described (Heffernan, Thomason et al. 2007).  Groups of eight female mice 
age 6-8 weeks were infected with 1.5x107 spores/mouse.  Mice were monitored for up to 
14 days following infection.   
Spore germination in bone marrow-derived macrophages (BMM) 
BMM were cultured and harvested as previously described (Swanson 1989).  
Briefly, bone marrow from the hind leg bones of two mice (4 femurs, 4 tibia), was pooled 
for wild-type or lysozyme M-/- genotypes.  Cells were differentiated in DMEM with 20% 
FBS and 30% L cell-conditioned medium.  Cultures were allowed to differentiate for one 
week.  Additional medium containing 30% L-cell conditioned medium was added at day-
3.   
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For spore germination assays, 4x105 BMM/well were seeded into 12-well tissue 
culture treated plates (Corning) and incubated overnight at 37oC and 5% CO2.  Cells were 
washed three times in 1.0 ml of HBSS (pre-warmed to 37oC).  Spores were diluted to 
4x107 spores/ml in MEM + L-glutamine and 1.0 ml was added to each well.  Plates were 
centrifuged at 200xg for 30 seconds to settle spores onto macrophages.  Spores and 
macrophages were incubated at 37oC and 5% CO2 for one hour.  Non-internalized spores 
were removed by washing macrophages with 1.0 ml of HBSS.  BMM were incubated for 
20 minutes at room temperature in 500 µl of MEM + L-glutamine + 20 µg/ml of 
gentamicin to kill any extracellular spores that may have germinated.   The gentamicin-
containing medium was removed by washing cells three times in 1.0 ml of HBSS.  Cells 
were scraped and lysed in 200 µl of MEM + 1% saponin.  Cell lysate was plated on BHI 
and cultured overnight at 37oC to measure the number of cfu.   
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Results 
Spores lacking GSLEs germinate in murine serum and purified lysozyme in vitro.  
A ΔsleB/cwlJ1/cwlJ2 mutant strain of B. anthracis is incapable of germinating in 
response to nutrients in vitro (Giebel, Carr et al. 2009).  Although these spores are highly 
attenuated in a mouse model of inhalation anthrax, they maintain an unexpected level of 
virulence (Giebel, Carr et al. 2009). This suggests that the ΔsleB/cwlJ1/cwlJ2 
germination rate must be higher in vivo than it is in nutrient rich medium in vitro. 
Colony-forming efficiency is increased when ΔsleB/cwlJ1/cwlJ2 spores are 
incubated in murine serum compared to BHI (Figure 3.1A).  Serum is an easily 
obtainable bodily fluid, and although not likely encountered during inhalational anthrax, 
it is likely to come into contact with spores in a cutaneous infection.  Colony-forming 
efficiency was determined by comparing the number of spores/ml, quantified visually 
using a haemocytometer, to the numbers of cfu/ml when incubated in various germinants.  
When ΔsleB/cwlJ1/cwlJ2 spores were incubated in BHI prior to plating, colony-forming 
efficiency was below our limit of detection, as expected (Figure 3.1A).  When 
ΔsleB/cwlJ1/cwlJ2 spores were incubated in murine serum prior to plating on BHI, 
colony-forming efficiency was increased to 5.0x104 spores/cfu (Figure 3.1A).  When 
serum was heat-treated at 65oC for 20 minutes, the ability to induce ΔsleB/cwlJ1/cwlJ2 
spore germination (Figure 3.1A) was abolished.  These findings show that murine serum 
is capable of inducing ΔsleB/cwlJ1/cwlJ2 spore germination, and are in agreement with 
earlier published results using bovine serum (Giebel, Carr et al. 2009).   
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Figure 3.1: Colony-forming efficiency and corresponding lysozyme activity.   
Colony forming efficiency (A) was determined by visually assaying the number of spore 
particles/ml (black bar) using an improved Neubauer haemocytometer compared to the 
number cfu/ml (white bars) when tittered on BHI.  Lysozyme activity (B) was measured 
by release of fluorescently labeled substrate compared to a standard curve generated 
using purified lysozyme.  Data shown represent the mean value of three replicate 
experiments; error bars represent ±standard error. N.D.= none detected 
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The ability of serum to induce mutant spore germination is heat-sensitive; 
therefore I hypothesized that an enzyme might be involved.  As previously discussed, 
lysozyme was a prime candidate to compensate for the loss of native GSLE activity; 
therefore I tested the ability of purified lysozyme to induce ΔsleB/cwlJ1/cwlJ2 spore 
germination (Figure 3.1A).  When ΔsleB/cwlJ1/cwlJ2 spores were preincubated in a 
solution of purified hen egg-white lysozyme (10µg/ml) (HEWL), colony-forming 
efficiency was increased to 4.7x104 spores/cfu.  This indicated that lysozyme alone was 
sufficient to induce germination of ΔsleB/cwlJ1/cwlJ2 spores.     
I next measured lysozyme activity in murine serum and heat-treated murine serum 
to assess the correlation between the loss of the ΔsleB/cwlJ1/cwlJ2 germination 
phenotype and the loss of lysozyme activity (Figure 3.1B).   The average lysozyme 
activity in murine serum was found to be 480 ± 110 U/ml.  Following heat treatment, the 
lysozyme activity in mouse serum was reduced to 40 ± 17 U/ml.  These data show a 
correlation between lysozyme activity and ΔsleB/cwlJ1/cwlJ2 spore germination.   
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Lysozyme M enhances the virulence of a GSLE mutant in mice. 
 To test whether increased colony-forming efficiency of ΔsleB/cwlJ1/cwlJ2 spores 
in vitro is responsible for increased virulence in mice, I infected lysozyme M deficient 
mice with mutant spores.  These mice were in the FVB/NJ parental background rather 
than the DBA/2J background that was previously used to test the virulence of 
ΔsleB/cwlJ1/cwlJ2 spores.   
It has been shown that different inbred mouse strains have varying degrees of 
susceptibility to B. anthracis infection primarily based on the presence of the hemolytic 
complement deficient allele Hc0 (Welkos, Keener et al. 1986; Welkos and Friedlander 
1988).  Mouse strains containing the Hc0 allele are much more susceptible to 34F2 Sterne 
strain spores than those with wild-type alleles.   Because both DBA/2J and FVB/NJ mice 
contain the Hc0 allele, I predicted that FVB/NJ and Lysozyme M-/- mice would be 
similarly susceptible to 34F2 infection as DBA/2J mice were.  To verify this, FVB/NJ and 
lysozyme M-/- mice were infected with a single dose of wild-type spores (Figure 3.2A).  
Mice were infected intratracheally with 1.5x107 spores/mouse to simulate inhalational 
anthrax infection.  FVB/NJ mice were highly susceptible to this dose with 100% of the 
mice succumbing to the disease by day-3 post infection (Figure 3.2A).  This lethality rate 
is similar to previously published virulence studies using DBA/2J mice (Giebel, Carr et 
al. 2009; Carlson, Dixon et al. 2010; Carr, Lybarger et al. 2010).  At this dosage, 
lysozyme M-/- mice appear slightly more susceptible to 34F2 spores (p=0.06) (Figure 
3.2A).  All Lysozyme M-/- mice challenged with wild-type spores succumb to the 
infection after only one day.  This shows that FVB/NJ and lysozyme M-/- mice do not 
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have a generally increased resistance to B. anthracis infection and lysozyme M-/- might 
even be more susceptible than their parental background.  This suggests that lysozyme M 
may be involved in innate immunity during anthrax infection.  Although this is an 
intriguing observation, the experiments necessary to confirm this hypothesis were beyond 
the scope of this study.  
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Figure 3.2: Survival curves of FVB/NJ and Lysozyme M-/- mice challenged with 
wild-type and ΔsleB/cwlJ1/cwlJ2 spores.   
FVB/NJ () and lysozyme M-/- () mice (n=8 per group) were challenged intratracheally 
with 1.5x107 34F2 spores/mouse (A) or 1.5x107 ΔsleB/cwlJ1/cwlJ2 spores/mouse.  Mice 
were monitored for a period of 14 days post infection at which point any surviving mice 
were euthanized.  Lysozyme M-/- mice were found to be significantly protected from 
infection by ΔsleB/cwlJ1/cwlJ2 spores compared to FVB/NJ mice (p=0.004), by log-rank 
(Mantel-Cox) test. 
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FVB/NJ and Lysozyme M-/- mice were next challenged with ΔsleB/cwlJ1/cwlJ2 
spores to test the role of lysozyme M in ΔsleB/cwlJ1/cwlJ2 virulence.  Again mice were 
challenged intratracheally with 1.5x107 spores/mouse.  At this dose, 90% of wild-type 
mice succumb to the infection after 5 days (Figure 3.2B).  However, lysozyme M-/- mice 
infected with the same high dose of ΔsleB/cwlJ1/cwlJ2 spores did not develop disease 
(Figure 3.2B).  Only one mouse succumbed to the infection during the course of the 
experiment  (p=0.004).  These results show that deficiency of lysozyme M was 
associated with enhanced resistance to infection by ΔsleB/cwlJ1/cwlJ2 spores, likely due 
to decreased spore germination in vivo.  
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Spore germination in bone marrow-derived macrophages and serum from knockout 
mice 
 In inhalation anthrax, spore germination takes place in association with alveolar 
phagocytes following engulfment (Ross 1957).  To mimic this essential step in disease in 
vitro, I harvested bone marrow cells from the femurs of wild-type and lysozyme M-/- 
transgenic mice and cultured them in macrophage colony-stimulating factor to obtain 
bone marrow-derived macrophages (BMM).  4x105 BMM were infected at an MOI of 
100 and were treated with extracellular gentamicin following the challenge to ensure that 
only intracellular germination was being measured.  When BMM from wild-type mice 
were infected with ΔsleB/cwlJ1/cwlJ2 spores, an average of 99 ± 16 spores germinated 
following internalization (Figure 3.3).  However, no germination could be detected from 
ΔsleB/cwlJ1/cwlJ2 spores internalized by lysozyme M-/- BMM (Figure 3.3).  These data 
indicate that lysozyme M is required for ΔsleB/cwlJ1/cwlJ2 spore germination within 
macrophages.   
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Figure 3.3: ΔsleB/cwlJ1/cwlJ2 spore germination within bone marrow-derived 
macrophages.   
BMM were harvested from the hind leg bones of wild-type (FVB/NJ) and lysozyme M-/- 
mice.  Cells were differentiated in culture containing macrophage colony-stimulating 
factor.  Following incubation with spores, BMM were treated with gentamicin to kill any 
remaining extracellular spores that may have germinated. This insured only internalized 
spores were measured. Data shown represent the mean value of three replicate 
experiments; error bar represents ±standard error. N.D.= none detected 
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In addition to primary macrophages, filtered serum was also collected from 
lysozyme M-/- mice.  Colony-forming efficiency assays with ΔsleB/cwlJ1/cwlJ2 spores 
were preformed using wild-type serum as well as mutant mouse serum as germinants.  
Colony-forming efficiency of spores incubated in lysozyme M-/- serum remained at wild-
type serum levels (Figure 3.4A).  However, when lysozyme activity in this germinant was 
measured it was found to be approximately equal to that of wild-type serum (Figure 
3.4B).  Presumably, lysozyme P expression was upregulated in the absence of lysozyme 
M in serum.  To overcome this I collected filtered serum from a newly developed 
lysozyme MP-/- mouse strain.  This strain is completely devoid of lysozyme expression as 
verified by a lysozyme activity assay (Figure 3.4B).  Mutant spore germination could not 
be detected following incubation in this lysozyme negative serum (Figure 3.4A).  This 
shows that lysozyme alone is responsible for mutant spore germination in murine serum.  
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Figure 3.4: Colony forming efficiency of ΔsleB/cwlJ1/cwlJ2 spores in lysozyme 
deficient serum. 
Colony forming efficiency (A) was determined by visually assaying the number of spore 
particles/ml (black bar) using an improved Neubauer haemocytometer compared to the 
number cfu/ml (white bars) when tittered on BHI.  Lysozyme activity (B) was measured 
by release of fluorescently labeled substrate compared to a standard curve generated 
using purified lysozyme.  Data shown represent the mean value of two replicate 
experiments; error bars represent ±standard error. 
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Discussion 
 I have shown previously that mutant B. anthracis spores lacking sleB, cwlJ1 and 
cwlJ2 are completely blocked from in vitro germination in response to nutrients, but that 
these spores have higher than expected virulence in a mouse model of inhalation anthrax 
(Giebel, Carr et al. 2009).  Those results suggested that ΔsleB/cwlJ1/cwlJ2 germination 
rates in vivo were significantly increased.  The increased germination rate could be a 
result of an in vivo specific germinant, but this would require the presence of an unknown 
GSLE that can be activated by the in vivo specific germinant.  A much more likely 
explanation is that germination is being triggered in a non-nutrient dependent manner that 
bypasses the need for GSLEs.   
Besides nutrient-based germination, spores have been shown to germinate in 
response to a variety of non-nutrient stimuli including a 1:1 chelate of Ca2++ and 
dipicolinic acid (Paidhungat, Ragkousi et al. 2001), cationic surfactants (Rode and Foster 
1961; Setlow, Cowan et al. 2003), high physical pressure (Gould, Sale et al. 1969; Gould 
and Sale 1970) and lysozyme (Sekiguchi, Akeo et al. 1995; Popham, Helin et al. 1996).  
Exogenous calcium ions and dipicolinic acid induce germination by activating CwlJ 
(Paidhungat, Ragkousi et al. 2001).  Both cwlJ1 and cwlJ2 are lacking in the 
ΔsleB/cwlJ1/cwlJ2 mutant, so this germination pathway cannot account for its increased 
virulence.  High pressure would not be exerted on spores in vivo, and as such, would not 
contribute to the increased virulence.   
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The most likely pathway for increased ΔsleB/cwlJ1/cwlJ2 spore germination in 
vivo is cortex degradation by lysozyme.  Lysozyme degrades peptidoglycan by 
hydrolyzing the β-1,4 glycosidic bond between N-acetylglucosamine and N-
acetylmuramic acid (Ibrahim, Aoki et al. 2002).  Presumably, this enzymatic activity 
leads to spore germination by sufficiently disrupting the cortex allowing core rehydration 
and outgrowth without the need for GSLEs.  Also, there is a high likelihood that B. 
anthracis spores contact a high concentration of lysozyme in the airways of the host. It is 
estimated that the concentration of lysozyme in airway surface liquid is >100 µg/ml 
(Travis, Conway et al. 1999).  In addition to being located in several bodily fluids, such 
as saliva, tears and serum, lysozyme is abundant in alveolar macrophages and lung 
epithelial cells (Fleming 1922; Gordon, Todd et al. 1974; Cross, Mangelsdorf et al. 
1988).  Very early in an inhalational anthrax infection, spores are thought to encounter 
both of these cell types (Ross 1957). 
The role of lysozyme in ΔsleB/cwlJ1/cwlJ2 spore germination was further 
supported by in vitro germination assays.  Incubating ΔsleB/cwlJ1/cwlJ2 spores in BHI 
results in an extremely low colony-forming efficiency, below the limit of detection 
(2x106 spores/cfu) in our assay (Figure 3.1A).  When mutant spores were incubated in a 
solution of HEWL (10µg/ml), their colony-forming efficiency was increased at least 40-
fold to 4.7x104 spores/cfu (Figure 3.1A).  This demonstrates that lysozyme alone is 
sufficient to increase germination rates of ΔsleB/cwlJ1/cwlJ2 spores.  To test whether 
lysozyme could induce spore germination in a more natural environment, I began by 
exposing ΔsleB/cwlJ1/cwlJ2 spores to murine serum in vitro.  Although spores will not 
likely encounter serum-associated factors during inhalation anthrax, they would be 
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exposed to them during a cutaneous infection.  Similar to incubation in purified 
lysozyme, the colony-forming efficiency of ΔsleB/cwlJ1/cwlJ2 spores incubated in 
murine serum was increased at least 40-fold over that of spores incubated in BHI (Figure 
3.1A).  When serum was heat-treated, lysozyme activity was abrogated and its ability to 
induce ΔsleB/cwlJ1/cwlJ2 spore germination was abolished (Figure 3.1A and 3.1B).  
 Although this showed that lysozyme activity was correlated with the ability to 
cause germination, I did not observe a linear relationship.  Colony-forming efficiency of 
ΔsleB/cwlJ1/cwlJ2 spores incubated in serum or a solution of HEWL (10µg/ml) was 
approximately the same (5.0x104 spores/ml and 4.7x104 spores/ml respectively).   
However, the lysozyme activity of purified lysozyme was found to be approximately five 
times higher than that of murine serum (Figure 3.1B).  This suggests that there is a 
lysozyme activity threshold and that increased activity above this threshold will not lead 
to increased spore germination.  One possible explanation for these findings is that only a 
small percentage of spores allow lysozyme access to their cortex, presumably due to rare 
defects in the outer layers of the spore.  If true, this observation suggests a new function 
for these protective layers in the environment.  It is possible that the coat and exosporium 
have evolved to help maintain spore dormancy.  Without these layers, the spore would be 
susceptible to lysozyme and other peptidoglycan hydrolyzing enzymes that could cause 
premature germination.  The coats may shield the spore from these foreign enzymes 
allowing the spore’s natural nutrient sensing pathway to dictate the most favorable time 
to initiate germination.   
GSLEs play a critical role in B. anthracis virulence and their function is required 
for nutrient based spore germination (Giebel, Carr et al. 2009).  However, as 
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demonstrated by the ΔsleB/cwlJ1/cwlJ2 mutant, even if these critical enzymes could be 
completely inhibited some spores may still germinate leading to an active infection.  
When wild-type mice were challenged with 1.5x107 ΔsleB/cwlJ1/cwlJ2 spores, 90% 
succumb to the infection (Figure 3.2B).  However, when lysozyme M-deficient mice 
were challenged with the same dose, only one mouse succumbed to the infection (Figure 
3.2B).  This shows that host lysozyme is capable of germinating spores that would be 
otherwise unable to exit dormancy.  Based on our current understanding of anthrax 
pathogenicity, it is likely that the host lysozyme responsible for germinating these spores 
was encountered within alveolar macrophages and in the airway surface lining fluid.  
This theory is supported by in vitro data using BMM from wild-type and lysozyme M-/- 
mice.  A small percentage of ΔsleB/cwlJ1/cwlJ2 spores internalized by wild-type BMM 
were germinated (Figure 3.3).  However, no germination could be measured when spores 
were incubated in the presence of BMM from lysozyme M-/- mice.  This shows that the 
presence of lysozyme within a host macrophage, the most likely environment for a spore 
following inhalation, is sufficient to induce germination. 
 Although lysozyme is able to enhance/induce B. anthracis spore germination both 
in vitro and in vivo, it is unlikely that this pathway significantly contributes to disease in 
a natural infection.  Only a very small number of spores are susceptible to germination by 
lysozyme.  Therefore, lysozyme-induced germination events would certainly be 
overwhelmed by the number of spores that undergo germination in response to typical 
nutrient germinants encountered during infection.  Rather, these data collected using 
ΔsleB/cwlJ1/cwlJ2 spores as a tool to observe rare germination events, provides insight 
and questions into the use of spores as a dormant vaccine vector, the feasibility of 
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blocking GSLE activity to prevent disease, and the role of outer spore layers in 
preserving dormancy.   
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Chapter IV 
Discussion and Future Directions 
 The focus of this research was to further our understanding of cortex hydrolysis in 
B. anthracis.  Breakdown of the cortex is a critical transition step in germination and 
work by many groups over the past several decades has contributed greatly to our 
understanding of conserved hydrolytic enzymes that are needed to accomplish this.  
Chapter 2 outlines a traditional cortex hydrolysis pathway of B. anthracis.  As in other 
spore forming bacteria, B. anthracis employs the coordinated effort of several GSLEs 
that are packaged into the spore during sporulation and are only activated at a precise 
time when cortex hydrolysis is required.  Unexpected germination of mutants developed 
in Chapter 2 lead to the realization of an entirely separate mechanism for cortex 
hydrolysis.  This new mechanism, host-lysozyme induced germination, is characterized 
in Chapter 3.  Below I will discuss how this new pathway impacts current beliefs in the 
spore germination field.   
 
Host-lysozyme induced germination among other spore forming bacteria 
 The role of host-lysozyme induced germination, identified in Chapter 2 and 
further characterized in Chapter 3, has recently been applied to Clostridium perfringens 
spore germination research (Paredes-Sabja and Sarker 2011).  Indeed, published work 
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from Chapter 2 was cited as the impetus for this study.  C. perfringens is a Gram-positive  
spore forming bacteria that can cause a wide spectrum of disease (Amimoto, Noro et al. 
2007; Sayeed, Li et al. 2007; Sayeed, Li et al. 2010).  Following spore germination inside 
a host, toxins secreted by C. perfringens vegetative cells can cause gas gangrene, 
antibiotic-associated diarrhea, and a variety of other diseases.  As is the case for anthrax, 
spore germination inside the host is a critical step in disease initiation.  However, 
relatively little is known about C. perfringens spore germination in vivo.  A recent study 
by Paredes-Sabja and Sarker has suggested that host-lysozyme induced germination may 
be an important step in the early stages of C. perfringens pathogenesis (Paredes-Sabja 
and Sarker 2011). 
Three disease causing clinical isolates of C. perfringens showed rates of 
germination varying from 20% to 100% when incubated in the rich medium BHI 
(Paredes-Sabja and Sarker 2011).  However, all of these strains reached nearly 100% 
germination when they were incubated in sheep blood, sheep serum, or human serum.  
Blood or serum-induced germination was not diminished in mutants lacking germinant 
receptors.  This showed that serum-induced germination of C. perfringens spores is not 
dependent on nutrients and does not require traditional spore germination machinery.  As 
is the case in B. anthracis germination, C. perfringens spores lacking GSLEs do not 
germinate when incubated in BHI.  However, approximately 10% of GSLE deficient C. 
perfringens spores do germinate when incubated in serum or blood.  This phenotype is 
similar to serum based germination assays with ΔsleB/cwlJ1/cwlJ2 B. anthracis spores 
(Figure 2.4 and 3.1).  Size exclusion filtration and Western-blotting strongly implicated 
lysozyme as the serum component that was responsible for non-nutrient C. perfringens 
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germination (Paredes-Sabja and Sarker 2011).  The role of host lysozyme-induced 
germination on C. perfringens pathogenesis was not determined.  However, based on my 
findings in B. anthracis, I would predict that GSLE deficient C. perfringens spores would 
be attenuated in lysozyme deficient mice compared to wild-type mice.       
 It appears that both B. anthracis and C. perfringens spores are able to germinate 
in response to host lysozyme.  However, because of the much greater number of spores 
that can germinate in this way, host-lysozyme induced germination may be more 
biologically relevant in the case of C. perfringens infection.  As discussed in Chapter 2, 
only ~0.01% of GSLE deficient B. anthracis spores germinate in serum.  In analogous C. 
perfringens mutants, ~10% of spores are able to germinate when incubated in serum, an 
increase of 1000-fold over the B. anthracis response.  This suggests that compared to the 
minimal role of host lysozyme-induced germination in a B. anthracis infection, a much 
higher percentage of C. perfringens spores may germinate through this alternate route in 
vivo.  C. perfringens pathogenesis studies must be conducted to determine if host-
lysozyme induced germination does in fact play a critical role. 
A fundamental difference in spore coat composition and structure is a likely 
explanation for the varying rates of lysozyme-induced spore germination between these 
two species.  Removal of spore coats has shown that this structure provides protection 
from exogenous lytic enzymes such as lysozyme (Popham, Helin et al. 1996; Paredes-
Sabja and Sarker 2011).  In B. subtilis, the spore coat prevents degradation of spores 
phagocytosed by the protozoan Tetrahymena thermophila (Klobutcher, Ragkousi et al. 
2006).  The protein composition of spore coats in Bacillus species is quite conserved; 
however, very few of these proteins are found in the coats of Clostridium species 
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(Henriques and Moran 2007).  This difference in protein composition and likely coat 
structure could lead to varying accessibility of the cortex to exogenous lysozyme and 
therefore altered lysozyme-induced germination rates.   
Another possible explanation for variable sensitivity to host lysozyme between 
these two species is the exosporium.  The presence and morphology of this spore 
structure is highly variable across species but its function is very poorly understood 
(Hodgkiss, Ordal et al. 1967; Rode 1971; Driks 2007).  The molecular makeup of the B. 
anthracis exosporium has been partially defined but little is known about the chemical 
makeup of C. perfringens exosporium (Steichen, Chen et al. 2003; Liu, Bergman et al. 
2004).  Structural differences between the two species can be seen by electron 
microscopy but both appear to have a crystalline like basal layer with small pores that 
may allow the passage of small molecule germinants but probably do not allow large 
molecules such as lysozyme to pass through (Hoeniger, Stuart et al. 1968; Ball, Taylor et 
al. 2008).     Future studies using B. anthracis and C. perfringens spores with and without 
their exosporium are required to determine if the structural differences in this layer result 
in varying sensitivity to host-lysozyme.   
The chemical structure of cortex peptidoglycan has been studied in several spore-
forming bacteria including, B. anthracis and C. perfringens (Popham 2002; Dowd, 
Orsburn et al. 2008).  Only minor differences have been found between the two species 
making cortex sensitivity to lysozyme treatment an unlikely explanation for differential 
germination rates.  Regardless of the mechanism behind variable rates in host-lysozyme 
induced germination, it remains to be seen whether or not this difference represents an 
evolutionary strategy of either species to optimize virulence.    
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Vaccinology implications of lysozyme induced germination 
 Many attempts have been made to use Bacillus spores as vaccine vector platforms 
expressing recombinant antigen on their surface (Duc le, Hong et al. 2003; Oggioni, 
Ciabattini et al. 2003; Ferreira, Ferreira et al. 2005).  This approach offers potentially 
important advantages in vaccine development.  Spores are extremely resistant to 
environmental stresses.  They are able to withstand desiccation, extreme heat, and 
radiation (Setlow 2007).  The stability of the spore allows for an extremely long shelf life 
of the potential vaccine as well as transportation without regard to maintaining a cold 
chain.  Another potential advantage of bacterial spore vaccine vectors is an enhanced 
immune response due to cross presentation of spore surface proteins with the antigen of 
interest (Duc le, Hong et al. 2003).    
An obvious drawback to the use of live bacteria as a vaccine vector is a potential 
for pathogenesis.  For this reason B. subtilis is typically chosen because although it may 
pose a concern for severely immunocompromised patients, it is generally believed to be 
non-pathogenic in humans and animals (Sonenshein, Hoch et al. 1993).  However, some 
studies suggest that B. anthracis may produce better local and systemic immune 
responses due to its increased antigenicity (Ferreira, Ferreira et al. 2005).  Live B. 
anthracis spores of the attenuated Sterne strain have been used as vectors for veterinary 
vaccines to protect animals from B. anthracis infection, L. monocytogenes infection and 
C. perfringens toxins (Brossier, Mock et al. 1999).  Although B. anthracis Sterne strain 
has been used since the 1930’s as an anthrax vaccine for animals, and to a lesser extent 
humans, the remote possibility of infection and side effects such as fever and edema 
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caused by anthrax toxin prevent more widespread applications.  Attempts have been 
made to further inhibit toxin activity, through point mutations, without affecting 
immunogenicity (Pezard, Berche et al. 1991; Pezard, Weber et al. 1995).   An attractive 
alternative to fully detoxifying B. anthracis is blocking germination rendering the spores 
inert and incapable of causing disease.   
As attractive as this is however, this approach would be complicated by host 
lysozyme-induced germination.  As outlined in Chapter 3, even if spore germination 
machinery is completely disabled, some fraction of the population may still germinate.  
This alternate germination pathway must be considered in any future attempts to create 
vaccines based on B. anthracis spores.    
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Future Directions: The link between GSLE localization and silencing  
 A next step in understanding cortex hydrolysis in vivo is determining the 
silencing and activation mechanism of GSLEs.  The astonishing ability of GSLEs to 
remain silent for hundreds of years while in close proximity to their substrate and then be 
activated within a matter of minutes is very poorly understood.  Some information 
regarding the activation of CwlJ is known (Paidhungat, Ragkousi et al. 2001; Ragkousi, 
Eichenberger et al. 2003); however, nothing is known about the activation of SleB or the 
way in which germinant receptors transmit the signal to begin germination to these down 
stream enzymes.  One possible mechanism for GSLE silencing is sequestration during 
packaging.  Spore assembly during sporulation is a tightly regulated process.  Mother cell 
and forespore specific sigma factors ensure that most proteins packaged into the mature 
spore, including GSLEs, are expressed at a precise time point and from a precise location.  
It is possible that GSLE localization dictated during sporulation is the mechanism by 
which these enzymes remain silent.   
 Specific localization of GSLEs has been demonstrated by immunoelectron 
microscopy.  SleB in B. subtilis and B. cereus, and its homologue SleC in C. perfringens, 
are expressed in the forespore and localize to the outer layer of the cortex, just inside the 
spore coat (Miyata, Kozuka et al. 1997; Moriyama, Fukuoka et al. 1999).  The specific 
localization of SleB in B. anthracis spores has not yet been determined.  More 
importantly, nothing is known about the functionality of this enzyme if this localization 
pattern is disrupted.  
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Figure 4.1:  Conserved domain structure of full length and truncated SleB 
SS: signal sequence.  PGBD: peptidoglycan binding domain
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 SleB is a 253-amino-acid protein with a predicted signal sequence at its amino-
terminus and two conserved domains, a hydrolytic domain and a peptidoglycan-binding 
domain (PGBD) (Figure 4.1).   The hydrolytic domain is a member of the pfam07486 
hydrolases and is homologous to the hydrolytic domain in CwlJ1 and CwlJ2.  The PGBD 
is conserved among SleB homologues in B. subtilis and B. cereus, as well as a variety of 
other peptidoglycan hydrolyzing enzymes (Miyata, Moriyama et al. 1995; Moriyama, 
Hattori et al. 1996; Masayama, Fukuoka et al. 2006).   
In vitro studies showed that the hydrolytic domain was active in the absence of 
the PGBD but that SleB activity was increased 10-fold when the PGBD is present 
(Heffron, Sherry et al. 2011).  Full length SleB was able to bind purified peptidoglycan 
with nearly 100% efficiency.  The hydrolytic domain alone was also able to bind 
peptidoglycan (approximately 50% efficiency).  Interestingly, while full length SleB 
showed no preferential binding to cortex peptidoglycan over cell wall peptidoglycan, the 
hydrolytic domain alone preferentially bound to purified cortex (Heffron, Sherry et al. 
2011).  This suggests that the hydrolytic domain might dictate proper substrate binding 
during cortex hydrolysis.  Based on these in vitro studies, I developed the following 
hypothesis for SleB silencing and activation.  SleB is bound by its PGBD to the 
outermost region of the cortex where it does not have access to its substrate.  When the 
germination process is initiated, SleB is released and cortex hydrolysis begins. 
 To date I do not have conclusive evidence to support or reject this hypothesis, but 
I have begun preliminary experiments to visualize the localization of wild-type SleB as 
well as a truncated SleB protein that lacks a peptidoglycan-binding domain. I have made 
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sleB constructs that fuse a carboxy-terminal myc tag onto full length SleB (SleB-myc) 
and truncated SleB that lacks a PGBD (SleBΔPGBD) (Figure 4.1). These proteins were 
expressed in a GSLE null strain of B. anthracis (ΔsleB/cwlJ1/cwlJ2).  Using these strains 
expressing tagged proteins, I have begun to track wild-type and truncated SleB 
localization by immunoelectron microscopy.  Preliminary results show possible full-
length SleB localization to the outer layer of the cortex, similar to what has been 
observed in B. subtilis and B. cereus (Figure 4.2A).  However, localization of 
SleBΔPGBD has not been detected as of yet (Figure 4.2B).  Experimental conditions 
need to be refined to increase the detection of full length as well as truncated protein.   
In addition to testing the role of the PGBD in SleB localization in the dormant 
spore, this system could be used to track any movement of SleB throughout germination.  
Once the experimental conditions have been optimized, spores expressing myc-tagged 
full length SleB could be fixed at various time points following incubation in germinants. 
This experiment would show if SleB localization changes upon initiation of germination 
as predicted by my hypothesis.  Future work to refine these results can identify the 
cellular localization of SleB throughout this process and whether or not proper 
localization requires the PGBD.   
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Figure 4.2: Immunoelectron microscopic localization of full length and truncated 
SleB. 
Spores expressing myc-tagged SleB (A) and myc-tagged SleBΔPGBD (B) were fixed in 
4% paraformaldehyde and ultra-thin sections were taken.  Samples were stained with C-
myc mouse monoclonal antibody [9E10] and goat anti-mouse IgG secondary antibody 
conjugated to 10nm gold particles.  The sections were examined using a Philips CM100 
electron microscope at 60kV.  Images were recorded digitally using a Hamamatsu 
ORCA-HR digital camera system operated using AMT software (Advanced Microscopy 
Techniques Corp., Danvers, MA). 
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Conclusion 
 The entire germination process, and especially cortex degradation, represents a 
fascinating example of enzymatic regulation.  The bacterial spore is nature’s loaded gun.  
Everything it needs to fire is incorporated during sporulation and yet it is able to remain 
silent for centuries, if not millennia, until the trigger is pulled by the proper germinant 
and the spore’s germination potential is released with incredible speed.  
The studies presented in this thesis outline a conventional role for B. anthracis 
GSLEs that has been seen in the germination of many other spore-forming species.  
Much more interestingly, this work goes on to describe a new mechanism by which 
spores exit dormancy in vivo.  The existence of this alternate germination pathway that 
relies on host-lysozyme sheds new light on potential functions of spore coats and 
exosporium.  It is unclear whether host-induced lysozyme germination is an 
evolutionarily designed mechanism for in vivo germination or is a detrimental process 
that should be avoided until the spore germinates via its endogenous machinery following 
recognition of traditional nutrient germinants.  It is very possible that the positive or 
negative implications of this pathway are species specific and that different spore forming 
pathogens have optimized their outer protective layers, to enhance or inhibit this event.  
Future studies on the vast array of spore coats and spore appendages, as well as the role 
of host-lysozyme germination in the pathogenesis of other spore forming bacteria will 
further our understanding of host pathogen interactions in these diseases.   
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Appendix I 
Germination by Calcium and Dipicolinic Acid 
 This appendix includes data describing the activation of CwlJ1 and CwlJ2 by 
exogenous Ca2+ and dipicolinic acid. 
BACKGROUND 
 Spore germination is an irreversible chain of events that is preprogrammed during 
sporulation (Setlow 2003).  At that time, all of the proteins required to complete the 
transition back to a vegetative cell are packaged into the mature spore (Liu, Bergman et 
al. 2004).  However, during a spore’s extended dormant phase, these proteins must 
remain silent to maintain the spore’s integrity in the environment.  As outlined in Chapter 
1 (Figure 1.4), germination events are separated into early events (stage I germination) 
and late events (stage II) germination.  Recognition of germinants by receptors in the 
inner membrane is the signal that sets these pre-programmed events into action; however, 
the mechanism by which that signal is conveyed to GSLEs, which are activated in stage 
II germination, is unclear (Setlow, Melly et al. 2001).   
 To date, the only evidence of a possible mechanism for this signaling is the 
activation of CwlJ by a 1:1 chelate of exogenous Ca2+ and DPA (Paidhungat, Ragkousi et 
al. 2001; Ragkousi, Eichenberger et al. 2003).  It was first shown by Riemann and Ordal 
in 1961 that a 1:1 ratio of Ca2+ and DPA would induce spore germination in C. 
perfringens, B. subtilis, B. cereus, and several other Bacillus species (Riemann and Ordal 
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1961).  This method of spore germination was not dependent on the presence of 
germinant receptors and therefore believed to act downstream in the germination cascade 
(Paidhungat and Setlow 2000).  In B. subtilis, CwlJ is required for Ca2+/DPA germination 
(Paidhungat, Ragkousi et al. 2001; Ragkousi, Eichenberger et al. 2003).  It was suggested 
that this method of CwlJ activation may occur in natural germination when ions and DPA 
are released from the spore core following stage-I germination (Paidhungat, Ragkousi et 
al. 2001).  Unlike B. subtilis, B. anthracis encodes two CwlJ homologues, CwlJ1 and 
CwlJ2.  The effect of Ca2+/DPA on activation of these enzymes or their relative 
contributions to germination in response to Ca2+/DPA has not been defined.  Here I will 
present data from germination assays of wild-type and GSLE deficient spores incubated 
in Ca2+ and DPA to define the response of SleB, CwlJ1 and CwlJ2 to this non-nutrient 
germination pathway.   
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Materials and Methods 
 
Bacterial strains 
Bacterial strains and plasmids used in this study are listed in Table A1.1.   Vegetative B. 
anthracis cultures were grown in brain-heart infusion media (BHI, Difco) and 
Escherichia coli cultures were grown in Luria-Bertani (LB) medium (Sambrook and 
Russell 2001). B. anthracis spore stocks were prepared as previously described (Kim and 
Goepfert 1974; Dixon, Fadl et al. 2000).  Mutant bacterial strains were constructed using 
the allelic exchange method as previously described (Janes and Stibitz 2006; Lee, Janes 
et al. 2007). 
 
Germination Assays 
Spore germination was measured by loss of heat sensitivity.  Spore stocks were diluted to 
approximately 4x105 spores/ml and heat activated by incubation at 65oC for 20 minutes.  
Germination was initiated by adding 10 µl of spores to 2.0 ml of 60mM CaCl2 and DPA 
pH=8.5.  At each time point (2, 5, 10, 15, 20, and 30 minutes) 100 µl aliquots of this 
solution were removed, incubated at 65oC for 20 minutes, then 50 µl was plated onto BHI 
agar and incubated overnight.  Colonies that formed represented spores that failed to 
germinate and were therefore heat resistant.  As a control, 50 µl of spores at time 0 were 
plated without heat treatment.  The fraction of germinated spores for each time point was 
calculated as (1-tn)/t0 and reported as a percentage.   
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Table A1.1: Bacterial strains and plasmids 
Strain Relevant Characteristics Reference 
Sterne 34F2 Wild-type (pXO1+, pXO2-) (Sterne 1939) 
KC63 34F2, ΔsleB ΔypeB This work 
JG48 34F2, ΔcwlJ1 This work 
JG49 34F2, ΔcwlJ2 This work 
JG50 34F2, ΔsleB ΔypeB ΔcwlJ1 This work 
JG51 34F2, ΔsleB ΔypeB ΔcwlJ2 This work 
JG52 34F2, ΔcwlJ1 ΔcwlJ2 This work 
JG54 E. coli, BL21 pJDG105 This work 
 
Plasmids Relevant Characteristics Reference 
pBKJ236 Allelic exchange vector, Emr (Janes and Stibitz 
2006) 
pBKJ258 Allelic exchange vector, Kanr (Lee, Janes et al. 
2007) 
pBKJ223 Tetr, Pamy I-SceI (Janes and Stibitz 
2006) 
pJDG101 ΔsleB construct cloned in pBKJ258 This work 
pJDG102 ΔypeB construct cloned in pBKJ258 This work 
pJDG103 ΔcwlJ1 construct cloned in pBKJ236 This work 
pJDG104 ΔcwlJ2 construct cloned in pBKJ258 This work 
pJDG105 pET300/NT-DEST:cwlJ1 This work 
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Western Blot and Antibody Production 
Recombinant CwlJ was expressed under an IPTG-inducible promoter with an N-
terminal 6xHistidine fusion in BL21 E. coli cells.  Protein purification was preformed 
using Talon metal affinity resin.  Purified recombinant protein was sent to Rockland 
Immunochemicals Inc. (Gilbertsville, PA) for rabbit immunization and serum collection. 
 CwlJ1 protein expression in B. anthracis spores was measured by SDS-PAGE and 
Western blotting with a rabbit polyclonal antibody.  Prior to separation on a gel, spores 
were mechanically disrupted using a bead beater and 0.1mm glass beads.  
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Results and Discussion 
 Loss of heat resistance was used as a marker for germination of wild-type and 
mutant B. anthracis strains incubated in 60mM CaCl2 and DPA (Figure A1.1).  Wild-type 
Sterne 34F2 spores reach approximately 100% germination within the first 15 minutes 
(Figure A1.1A).  Previous studies have shown that spore germination in response to Ca2+ 
and DPA requires the enzyme CwlJ (Paidhungat, Ragkousi et al. 2001; Ragkousi, 
Eichenberger et al. 2003).  B. anthracis mutants lacking cwlJ1, cwlJ2, or both 
(ΔcwlJ1/cwlJ2) were tested for germination rates in 60mM CaCl2 and DPA to assay 
whether one or both of these genes were required for this type of germination.  Individual 
gene deletions ΔcwlJ1 and ΔcwlJ2 showed intermediate defects in response to Ca2+/DPA 
(Figure A1.1A).  Spores lacking CwlJ2 were delayed in the start of germination and only 
reached 74±12% germination in 30 minutes compared to 95±6% for wild-type.  Spores 
lacking CwlJ1 were even more defective in response to Ca2+/DPA with only 26±11% of 
spores being able to germinate within 30 minutes. When spores lacking both CwlJ1 and 
CwlJ2 were incubated in Ca2+ and DPA, germination was completely abolished.  These 
results suggest that although both CwlJ1 and CwlJ2 contribute to Ca2+/DPA germination, 
CwlJ1 activity is more important.   
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Figure A1.1:  B. anthracis spore germination in 60mM Ca2+ and DPA. 
Spores were incubated in 60mM CaCl2 and DPA pH8.5 at 37°C for 0-30 min (A and B) 
or 0-120 sec (C).  Percent germination was monitored by loss of heat resistance.  Panels 
A and B represent mean values from at least 3 independent experiments, error bars 
represent ±standard error. 
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 In addition to CwlJ mutants, spores lacking SleB were assayed to test whether 
exogenous Ca2+ and DPA affected SleB activity.  Spores lacking SleB (ΔsleB) reached 
100% germination within the first two minutes, the first time point measured (Figure 
A1.1B).  This hypergermination phenotype was a very surprising result, as the SleB 
homolog in B. subtilis has no reported effect on Ca2+/DPA germination.  It is also 
counterintuitive that the loss of a GSLE (SleB is highly active in all other germinants 
tested) could lead to an increase in germination rate.  To measure how quickly ΔsleB 
spores lost their heat resistance, the germination assay was repeated, this time taking 15-
second time points for 0-2 minutes (Figure A1.1C).  At the earliest time point, 15 
seconds, ΔsleB spores had already reached 92% germination.  These data indicate that 
ΔsleB spores lose their heat resistance almost immediately upon exposure to exogenous 
Ca2+ and DPA.  As shown in Chapter 2 this phenotype is specific to Ca2+/DPA 
germination and is not seen with nutrient based germinants (Figure 2.1).   
 Double mutants ΔsleB/cwlJ1 and ΔsleB/cwlJ2 and the triple mutant 
ΔsleB/cwlJ1/cwlJ2 were also tested for the ability to germinate in exogenous Ca2+ and 
DPA (Figure A1.1B and data not shown).  Spores lacking SleB and CwlJ2 exhibited a 
hypergermination phenotype very similar to ΔsleB.  Spores lacking SleB and CwlJ1 did 
not have a hypergermination phenotype, however the germination rate was significantly 
increased, approximately to that of wild-type spores. Spores lacking all GSLEs 
(ΔsleB/cwlJ1/cwlJ2) did not germinate when incubated in Ca2+ and DPA (data not 
shown).  These data suggest that loss of SleB induces a hypergermination phenotype, but 
that this response requires CwlJ1. 
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 I hypothesized that loss of sleB affected the expression level of cwlJ1, causing 
hypergermination as a result of increased CwlJ1 protein levels.  I tested this by Western 
blot using a polyclonal antibody against CwlJ1.  No obvious change in CwlJ1 protein 
level could be detected between wild-type, ΔsleB, and ΔsleB/cwlJ2 (Figure A2.1).   
It is possible that lack of SleB affects CwlJ1 activity, localization, or substrate 
binding affinity.  Enzymatic activity assays using purified enzymes in vitro could identify 
possible regulatory roles of SleB on CwlJ1. Similarly, SleB may bind to CwlJ1 in the 
spore and limit its ability to respond to Ca2+ and DPA.  Direct binding studies would be 
difficult because the harsh conditions required to break down the spore would likely 
disrupt protein-protein interactions between these enzymes.  It may be possible to 
visualize potential co-localization of SleB and CwlJ1 by immunoelectron microscopy 
with two different secondary antibodies conjugated to different sized gold particles.   
Further studies are required to define the mechanism of this surprising phenotype.   
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Figure A1.2:  CwlJ1 expression in ΔsleB spores.   
Total protein extract from wild-type (WT), ΔsleB, and ΔsleB/cwlJ2 spores was separated 
by SDS-PAGE.  CwlJ1 protein was detected by western blot with an anti-CwlJ1 
polyclonal antibody. 
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